Significance Statement {#s1}
======================

During childhood and adolescence, heightened neuroplasticity allows the brain to reorganize and adapt to its environment. Disruptions in these malleable phases can result in permanent neurodevelopmental disorders. To identify pathological mechanisms that disrupt developmental neuroplasticity, we applied a systematic computational screen of hundreds of diseases for their impact on neuroplasticity. We discovered that inflammation would putatively disrupt neuroplasticity and validated this hypothesis in an *in vivo* experimental mouse model of developmental cortical plasticity. This work suggests that inflammation during the childhood period could have unrecognized negative consequences on the neurodevelopmental trajectory.

Introduction {#s2}
============

During childhood and adolescence, the human brain undergoes tremendous reorganization during windows of heightened neuroplasticity. These windows of plasticity are critical periods that allow brain circuits to be refined by sensory and social experiences, which help to establish normal perception and higher cognitive function ([@B28]; [@B48]; [@B37]; [@B53]; [@B47]; [@B18]). Disruption of these critical periods can alter neural circuits that shape function and behavior, which may, in turn, contribute to a wide range of psychiatric and neurodevelopmental disorders, such as autism ([@B66]; [@B34]; [@B60]; [@B35]). Previous studies focused on several genes relevant to autism spectrum disorders (*MeCP2*, *Ube3a*, *Fmr1*) and identified marked disruptions in developmental cortical plasticity ([@B61]; [@B69]; [@B23]). To our knowledge, no studies have conducted a systematic evaluation of pathological mechanisms that may disrupt developmental plasticity. The goal of this study was to leverage the growing repository of publically available transcriptome data from diverse disease states to identify pathological processes with the capacity to disrupt developmental cortical plasticity.

To identify pathological processes that disrupt developmental plasticity, we designed an integrative bioinformatics approach that identifies disruptive pathways through systematic evaluation of molecular profiles of disease states in humans and animals. Our approach adapts molecular matching algorithms from computational drug repurposing (for review, see [@B24]) to match transcriptional signatures of disease to those of neuroplasticity. To model plasticity, we leveraged the paradigmatic ocular dominance model of *in vivo* developmental plasticity ([@B68]) and generated transcriptional signatures from primary visual cortex (V1). We matched plasticity and disease signatures to produce a diverse list of diseases ranked by their likelihood to dysregulate developmental plasticity. Across this ranked list, we sought to identify shared pathophysiology, rather than generate hypotheses about individual disease matches. To quantify shared pathophysiology, we developed and applied a novel Disease Leverage Analysis (DLA) that identifies shared molecular patterns of disease signatures to reveal novel disruptors of developmental plasticity. By examining shared pathophysiology, DLA identified a strong relationship between the molecular signatures of inflammation and developmental plasticity. We tested the hypothesis that inflammation disrupts developmental plasticity in the ocular dominance model of developmental V1 plasticity and found that functional, experience-dependent plasticity *in vivo* was suppressed by systemic inflammation. Our study demonstrates the utility of an integrative bioinformatics approach for identifying disruptors of developmental neuroplasticity and suggests that inflammation may be an unrecognized risk factor for neurodevelopmental disorders.

Materials and Methods {#s3}
=====================

Animals {#s3A}
-------

Male C57BL/6 mice (Charles River Laboratories) and *Lynx1*^−/−^ mice ([@B41]; a gift from Dr. Nathaniel Heintz, Rockefeller University, New York, NY) were group housed (three to five animals per cage) under a standard 12 h light/dark cycle (lights on at 7:00 A.M., lights off at 7:00 P.M.) with constant temperature (23°C) and *ad libitum* access to food and water. The Institutional Animal Care and Use Committee at the Icahn School of Medicine at Mount Sinai approved all procedures involving animals.

Substances {#s3B}
----------

Lyophilized *Escherichia coli* lipopolysaccharide (LPS; 600,000 endotoxin units/mg; serotype 0127:B8, catalog \#L5024, lot 073M4024V, Sigma-Aldrich) was reconstituted in sterile saline (0.9% NaCl) to yield a stock solution of 2 mg/ml, which was diluted with saline on the day of injection to yield a working concentration of 0.03 mg/ml.

Plasticity signature generation {#s3C}
-------------------------------

Transcriptomes were profiled with microarray to generate plasticity signatures. Experiment-naive juvenile C57BL/6 mice at postnatal day 29 (P29), adult *Lynx1*^−/−^ mice (\>P60), and adult C57BL/6 mice (\>P60; *n* = 3 each group) were anesthetized with isoflurane and cervically dislocated; bilateral V1 was removed, immediately frozen on dry ice, and stored at −80°C until processed. Total RNA was extracted from V1 using RNeasy Lipid Tissue Mini kit (Qiagen) and stored at −80°C. A total of 4.5 μg of cRNA was hybridized to Illumina WG-6 2.0 microarrays (750 ng/subarray). A juvenile plasticity signature was generated via differential expression analyses of juvenile versus adult V1 transcriptomes by first quantile normalizing probe-level data with limma ([@B56]) and then computing rank-based differential expression with RankProd ([@B25]; both R packages available through the Bioconductor repository) to yield 193 unique mouse Entrez IDs. For downstream analysis, mouse Entrez IDs were mapped to human orthologs using the Mouse Genome Informatics homology reference to yield a 176 gene juvenile plasticity signature. We generated a *Lynx1*^−/−^ signature in an analogous manner to juvenile, to yield a *Lynx1*^−/−^ plasticity signature of 98 genes. Raw data for plasticity signatures is freely available at the Gene Expression Omnibus under accession number GSE89757.

Molecular matching algorithm {#s3D}
----------------------------

To identify diseases that are predicted to dysregulate plasticity signature genes, we developed a molecular matching score, which is the sum of the absolute value of the rank-difference gene expression measure of disease signatures (for details of this expression measure, see [@B14]) that intersect with neuroplasticity signature genes. The absolute value was chosen to simplify downstream interpretation. This score is similar in spirit to the approach taken by [@B70], except in our implementation high scores indicate significant overlap between disease and plasticity signatures, whereas low scores indicate little or no overlap. To compare match scores (M) across diseases, we normalized the scores with *n* = 10,000 permutations of scores using $\frac{\text{M}_{actual}\, - \,{\overline{M}}_{perm}}{\sqrt{\frac{\sum_{i = 1}^{n}{(\text{M}_{perm_{i}} - {\overline{M}}_{perm})}^{2}}{n - 1}}}.$ *p* Values were estimated using the Generalized Pareto Distribution ([@B31]) on *n* permutations and were multiple test corrected using the method of [@B4].

Disease Leverage Analysis {#s3E}
-------------------------

We developed DLA to infer pathological processes that are shared across diseases and predicted to dysregulate plasticity signature genes. For pathological processes, we used the 50 "hallmark" gene sets (MSigDb; [@B58]). We computed a pathology score for each hallmark gene set for each disease signature, for a total of 50 × 436 = 21,800 scores. A pathology score is the sum of the absolute value of the normalized disease signature gene expression that is shared with a hallmark gene set. The absolute value was chosen because the direction of effect for gene sets is not necessarily known. We next calculated a linear regression between the pathology scores for a specific gene set and the plasticity--disease molecular match scores. We estimated the *p* value for the association between the pathology scores and disease--plasticity scores (the β~1~ coefficient) by computing 20,000 permutations of pathology scores using gene sets the same length as the input gene set and then calculating the regression on the permuted scores. If $\sum\limits_{i = 1}^{n}\lbrack\mathbb{1}_{\lbrack\,|\,\text{β }1_{perm_{i}}|\, > \,|\,\text{β}1_{actual}\,|\,\rbrack}\rbrack\, > \, 10$, where 𝟙 is the indicator function (i.e., the value is 1 when the conditional is satisfied and 0 otherwise) and *n* = the number of permutations, the *p* value was the empirical estimate: $\frac{\left. \sum_{i = 1}^{n} \middle| \,\,\text{β}1_{perm_{i}}\, \middle| \, > \, \middle| \,\text{β}1_{actual}\, \right|}{n}$; otherwise, the Generalized Pareto Distribution was used to estimate the *p* value ([@B31]). Bonferroni's method was used to correct for multiple hypothesis tests (denoted *p*~corrected~ in the text). To account for the probability of a large coefficient by chance, actual β~1~ coefficients were normalized by the permutated distribution of β~1~ according to $\frac{\text{β}1_{actual}\, - \,{\overline{\text{β1}}}_{perm}}{\sqrt{\frac{\sum_{i = 1}^{n}{(\text{β}1_{perm_{i}} - {\overline{\text{β1}}}_{perm})}^{2}}{n - 1}}}.$ Positive β values are pathological processes associated with diseases that were predicted to disrupt plasticity signatures. Negative β values are pathological processes associated with diseases that are predicted to not disrupt plasticity signatures. To calculate enrichments of top DLA gene sets, we chose a conservative cutoff of *p*~corrected~ \< 5 × 10^−5^ and then calculated the over-representation of inflammation gene sets among positive DLA associations. To do so, we used the hypergea (Bönn, 2016) R package, which uses a conditional maximum likelihood estimate to compute the odds ratio (OR) on adjusted cell counts (to avoid empty cells) and obtains two-sided *p* values from the hypergeometric distribution.

Quantitative PCR {#s3F}
----------------

Experiment-naive juvenile mice (P26; *n* = 5/group) were lightly anesthetized with isoflurane to avoid additional stressors and injected intraperitoneally before 12:00 noon eastern standard time with a dose of LPS that does not cross the blood--brain barrier ([@B3]; 300 μg/kg, ∼4.5 μg/mouse) or vehicle (150 μl of saline). Four hours later, mice were deeply anesthetized with isoflurane and decapitated, and bilateral V1 was removed under RNAse-free conditions, briefly rinsed in sterile saline (0.9% NaCl), immediately frozen on dry ice, and transferred to −80°C storage until processed. Total RNA was extracted from V1 using the RNeasy Lipid Tissue Mini Kit (Qiagen) and stored at −80°C. RNA yields ranged from 4.5 to 10 μg/sample and RNA integrity numbers ranged from 8.7 to 10 (mean, 9.8; SD, 0.32). Total V1 RNA was converted to cDNA using a High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Quantitative PCR (qPCR) was performed by the Mount Sinai Quantitative PCR core facility using TaqMan probes (catalog numbers: *NogoR*: 00445861, *Lynx1*: 01204957_g1, *S100a8*: 00496696_g1, *Lrg1*: 01278767_m1, *Lcn2*: 01324470_m1, *PirB*: 01700366_m1, *Cldn5*: 00727012_s1, *Egr2*: 00456650_m1, *Npas4*: 01227866_g1, Il1: 00434228_m1, *Agmat*: 01348862_m1, *Ch25h*: 00515486_s1, *Alox12b*: 01325300_gH, *Evpl*: 01700609_m1, *Slc40a1*: 00489835_g1, *Arc*: 01204954_g1, *S100a9*: 00656925_m1, *H2D1/H2K1*: 04208017_mH, *BDNF*: 04230607_s1, *Nptx2*: 00479438_m1, and *Ppp3ca*: 01317678_m1, Applied Biosystems). Quantification of the fold change was derived via the --ΔΔ CT method (equivalent to a log2 fold change) and significance was computed with parametric *t* tests of the Δ CTs, given the approximately normal distribution of Δ CTs. To prioritize qPCR validations, we identified the most differentially dysregulated juvenile neuroplasticity genes by an independent LPS brain study (GSE3253) by subsetting with the LPS brain expression whose absolute expression statistic was ≥2 after conversion to *z*-score.

*In vivo* electrophysiology {#s3G}
---------------------------

Under light isoflurane anesthesia, the contralateral eye of experiment-naive P26 mice was sutured, and the animal was immediately injected intraperitoneally with LPS (300 μg/kg, ∼4.5 μg/mouse) or vehicle (150 μl saline). Three days later, single-unit electrophysiological recordings were taken in binocular zone of V1 in response to visual stimuli presented to each eye separately ([@B20]). Briefly, recording was conducted under nembutal/chlorprothixene anesthesia. Visually evoked single-unit responses were recorded with 16-channel silicone probes (NeuroNexus) in response to a high-contrast single bar generated by visage system (Cambridge Research Systems). The signal was amplified and thresholded (OmniPlex, Plexon). To ensure single-unit isolation, the waveforms of recorded units were further examined off-line (Offline Sorter, Plexon). For each animal, approximately 3--10 single units were recorded in each of the four to six vertical penetrations spaced evenly (250 μm intervals) across the mediolateral extent of V1 to map the monocular and binocular zones and to avoid sampling bias. Monocular zone was identified when three consecutive units solely registered contralateral responses within a single penetration \[ocular dominance score (ODS) of 1, see below for definition of ODS\]. Secondary visual cortex was identified by the reversal of retinotopy seen as the electrode was moved into the secondary visual cortex ([@B20]). Mice that experienced opening of the sutured eye or had poor recordings (\<10 cells/mouse or \<3 penetrations/mouse or lack of positive identification of monocular zone and secondary visual cortex) were excluded from further study. To analyze the electrophysiology data, normalized ocular dominance index (ODI) of single neurons was computed by a custom-made MATLAB code by peristimulus time histogram analysis of peak to baseline spiking activity in response to each eye: {\[Peak(ipsi) − baseline(ipsi)\] − \[Peak(contra) − baseline(contra)\]}/{\[Peak(ipsi) − baseline(ipsi)\] + \[Peak(contra) − baseline(contra)\]}, which produces a range of \[−1,+1\] where −1 is a completely contralateral dominated cell and +1 is a completely ipsilateral dominated cell. ODI is linearly transformed by assigning \[−1.0, −0.5) = **1**, \[−0.5, −0.3) = **2**, \[−0.3, −0.1) = **3**, \[−0.1, +0.1\] = **4**, (+0.1, +0.3\] = **5**, (+0.3, +0.5\] = **6**, (+0.5, +1.0\] = **7** to produce the ODS. Finally, the contralateral bias index (CBI), a monocular weighted, animal-level summary statistic, is computed from the ODS, as follows: \[(*n***1** − *n***7**) + 2/3(*n***2** − *n***6**) + 1/3(*n***3** − *n***5**) + *N*\]/2*N*, where *N* = total number of cells and *n***x** = number of cells corresponding to ODS of **x**. Thus, a CBI value of 0.7 is contralateral dominant, and a CBI value of 0.4 is ipsilateral dominant. For statistical comparison of ocular dominance, ODSs of single neurons were plotted as a proportion histogram and compared via a nonparametric χ^2^ test, and CBI values of single animals were compared via a *t* test. Saline-treated juvenile animals (age P26) were the comparison group. The experimenter was blind to the sample group. Sample sizes were statistically estimated prior to undertaking experimental work to be *n* = 6 per group, assuming the effect sizes seen in previous relevant work.

Statistical analysis {#s3H}
--------------------

All statistical and computational analyses conducted with R (version 3.2.2) and Python (version 2.7.10). Parametric Welch *t* tests were two sided, unless otherwise noted. Sample sizes (denoted *n*) always indicate the number of mice. The influenza 95% confidence interval (CI) for the incidence rate ratio was estimated using the Katz log approach ([@B16]) $\left( e^{log(IRR) \pm \sqrt{\frac{1}{a} + \frac{1}{b} - \frac{1}{m} - \frac{1}{n}}} \right)$, where *a* and *b* are the successes and *m* and *n* are the totals (totals determined by dividing the successes by the published incidence rates. The detail of statistical analysis is shown in [Table 1](#T1){ref-type="table"}.

###### 

Statistics

  Subscript   Data structure         Type of test                                                                                                                                                          Power
  ----------- ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------
  a           Hypergeometric         Fisher\'s exact                                                                                                                                                       95% CI = 1.4--491.2
  b           Hypergeometric         Fisher\'s exact                                                                                                                                                       95% CI = 23.8--58.0
  c           Hypergeometric         Fisher\'s exact                                                                                                                                                       95% CI = 3.2--1229.8
  d           Approximately normal   Welch *t* test                                                                                                                                                        95% CI = −3.3 to −1.6, alternative hypothesis: true difference in means is not equal to 0
  e           Non-normal             Empirical *p* value                                                                                                                                                   NA
  f           Non-normal             Spearman rank correlation                                                                                                                                             NA
  g           Approximately normal   Welch *t* test                                                                                                                                                        NA; no specific *p* values reported, rather a group of genes under a specified *p* value threshold
  h           Approximately normal   Welch *t* test                                                                                                                                                        95% CI = −3.0 to −0.1, alternative hypothesis: true difference in means is not equal to 0
  i           Approximately normal   Welch *t* test                                                                                                                                                        95% CI = −1.3 to −0.1, alternative hypothesis: true difference in means is not equal to 0
  j           Approximately normal   Welch *t* test                                                                                                                                                        95% CI = 0.3--1.6, alternative hypothesis: true difference in means is not equal to 0
  k           Approximately normal   Welch *t* test                                                                                                                                                        NA; no specific *p* values reported, rather a group of genes above a specified *p* value threshold (e.g., not significant)
  l           Approximately normal   Welch *t* test, one-sided (due to specific prior hypothesis as to direction of effect; results still significant using a two-sided test at a threshold of α = 0.05)   95% CI = 0.1 to ∞\], alternative hypothesis: true difference in means is not equal to 0
  m           Non-normal             χ^2^ test of ODS counts                                                                                                                                               NA

Results {#s4}
=======

Molecular matching between plasticity and disease signatures {#s4A}
------------------------------------------------------------

To enable molecular matching between plasticity and disease, we compared V1 transcriptomes of juvenile wild-type mice, during the critical period of elevated ocular dominance plasticity in V1 ([@B20]), with adult wild-type mice with reduced plasticity, to identify a differential expression signature of 176 genes ([Fig. 1a](#F1){ref-type="fig"}; [Table 2](#T2){ref-type="table"}). We computationally matched this signature to 436 disease signatures derived from public microarray data using a previously described method ([@B14]; [Fig. 1a](#F1){ref-type="fig"}). This systematic method applies a rank-based molecular matching algorithm to determine the molecular concordance between the plasticity signature and a given disease signature, where high scores indicate plasticity genes are significantly dysregulated by the disease and low scores indicate that the disease has no impact on plasticity genes (for details, see Materials and Methods; [Fig. 1b](#F1){ref-type="fig"}). The molecular matching procedure produced a list of 436 diseases ordered by their prediction to disrupt the plasticity signature. Interestingly, highly ranked diseases included not only brain disorders known to disrupt plasticity, such as Huntington\'s disease ([@B62]; [@B44]; [@B40]), but also non-neurologic disorders (e.g., bacterial infections, inflammatory bowel disease, metabolic diseases), suggesting that a broad range of disease states may impact molecular pathways involved in plasticity.

![Diseases that dysregulate the juvenile plasticity signature are associated with inflammatory processes. ***a***, ***b***, Juvenile plasticity signature of 176 genes (represented by green bars) generated by differential expression of P29 vs \>P60 C57BL/6 male mice primary visual cortex was computationally matched to 436 disease signatures (represented by orange bars; ***a***) using rank-based molecular matching where large scores indicate shared transcriptional phenotype (***b***). ***c***, DLA systematically identified processes associated to diseases that dysregulate the plasticity signature. Seven of the 14 largest associations were inflammation-related gene sets, and 7 of 7 of inflammation-related gene sets were strongly associated with plasticity (all at *p*~corrected~ \< 5 × 10^−5^: OR = 25.8, 95% CI = 1.4--491.2, *p* = 2.7 × 10^−3^, Fisher's exact test). See [Figure 1-1](#F2){ref-type="fig"} for source DLA data.](enu0061622030001){#F1}

###### 

Juvenile plasticity signature

  RP         FC        pfp        *p* value   Probe_id       Symbol            mm_Entrez_ID   hs_Entrez_ID   Gene_name
  ---------- --------- ---------- ----------- -------------- ----------------- -------------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------
  2.8187     3.7313    0          0           ILMN_2641456   Pcp2              18545          126006         Purkinje cell protein 2 (L7)
  3.2916     3.422     0          0           ILMN_2503052   Tnnc1             21924          7134           Troponin C, cardiac/slow skeletal
  4.2819     3.1519    0          0           ILMN_2794645   Cyr61             16007          3491           Cysteine-rich protein 61
  13.632     2.5389    0          0           ILMN_1251414   Npas4             225872         266743         Neuronal PAS domain protein 4
  28.3181    2.375     0          0           ILMN_2597827   Arc               11838          23237          Activity-regulated cytoskeletal-associated protein
  15.7472    2.3415    0          0           ILMN_1230397   A630064P09Rik     NA             NA             NA
  15.7373    2.331     0          0           ILMN_2622983   Dusp1             19252          1843           Dual-specificity phosphatase 1
  14.4292    2.3046    0          0           ILMN_3160970   Gpr17             574402         2840           G-protein-coupled receptor 17
  16.9658    2.2123    0          0           ILMN_1250438   Marcksl1          17357          65108          MARCKS-like 1
  21.67      2.1606    0          0           ILMN_2710253   Cyr61             16007          3491           Cysteine-rich protein 61
  20.9478    2.1439    0          0           ILMN_1217458   8430403J19Rik     NA             NA             NA
  23.8738    2.111     0          0           ILMN_1220034   Junb              16477          3726           jun B proto-oncogene
  27.1365    2.0864    0          0           ILMN_2744890   Gadd45g           23882          10912          Growth arrest and DNA-damage-inducible 45 gamma
  25.9586    2.0549    0          0           ILMN_1227299   Mbp               17196          4155           Myelin basic protein
  29.3188    2.0001    0          0           ILMN_1239557   Ugt8a             22239          7368           UDP galactosyltransferase 8A
  27.0514    1.9972    0          0           ILMN_2619767   Pdlim2            213019         64236          PDZ and LIM domain 2
  32.1696    1.9948    0          0           ILMN_2707616   Col22a1           69700          169044         Collagen, type XXII, alpha 1
  32.3997    1.9656    0          0           ILMN_1221178   Pdlim2            213019         64236          PDZ and LIM domain 2
  38.5983    1.9267    5.00E-04   0           ILMN_2463181   Tnc               21923          3371           Tenascin C
  37.2206    1.9239    5.00E-04   0           ILMN_2810882   Ppic              19038          5480           Peptidylprolyl isomerase C
  41.0256    1.9217    5.00E-04   0           ILMN_2615034   Mog               17441          4340           Myelin oligodendrocyte glycoprotein
  37.2906    1.9117    5.00E-04   0           ILMN_2653205   Gp1bb             14724          2812           Glycoprotein Ib, beta polypeptide
  43.0584    1.9067    4.00E-04   0           ILMN_1212702   Hba-a1            NA             NA             NA
  47.3908    1.8855    8.00E-04   0           ILMN_1240973   Slc29a4           243328         222962         Solute carrier family 29 (nucleoside transporters), member 4
  145.4493   1.8339    0.0108     0           ILMN_1253365   Lypd1             71111          2863           G-protein-coupled receptor 39
  49.1546    1.832     8.00E-04   0           ILMN_2802263   Cnp               12799          1267           2\',3\'-cyclic nucleotide 3\' phosphodiesterase
  89.4321    1.8212    0.0037     0           ILMN_2491182   A130010C12Rik     NA             NA             NA
  85.0435    1.8206    0.0024     0           ILMN_2766894   Enpp6             320981         133121         Ectonucleotide pyrophosphatase/phosphodiesterase 6
  60.0087    1.7971    8.00E-04   0           ILMN_1223244   Hbb-b1            NA             NA             NA
  71.2786    1.7908    0.0012     0           ILMN_2906855   Ky                16716          339855         Kyphoscoliosis peptidase
  63.327     1.7828    7.00E-04   0           ILMN_2880906   Pdlim2            213019         64236          PDZ and LIM domain 2
  79.6764    1.7799    0.0024     0           ILMN_1256343   H19               14955          NA             H19, imprinted maternally expressed transcript
  100.4221   1.7744    0.0048     0           ILMN_1252953   Cbln1             12404          869            Cerebellin 1 precursor protein
  62.1078    1.7686    7.00E-04   0           ILMN_2617162   Mlp               17357          65108          MARCKS-like 1
  83.6683    1.7607    0.0025     0           ILMN_2955919   Mcam              84004          4162           Melanoma cell adhesion molecule
  70.6284    1.7566    0.001      0           ILMN_1259536   Mog               17441          4340           Myelin oligodendrocyte glycoprotein
  68.3987    1.753     0.001      0           ILMN_2754447   Mkrn3             22652          7681           Makorin, ring finger protein, 3
  68.3151    1.7464    0.001      0           ILMN_2597606   Gjc2              118454         57165          Gap junction protein, gamma 2
  95.7042    1.7345    0.0044     0           ILMN_2544056   Hbb-b1            100503605      3043           Hemoglobin, beta adult s chain
  76.7826    1.7239    0.0024     0           ILMN_1242456   Kank1             107351         23189          KN motif and ankyrin repeat domains 1
  82.1412    1.7197    0.0026     0           ILMN_1237021   Mag               17136          4099           Myelin-associated glycoprotein
  107.5658   1.7077    0.0049     0           ILMN_2675874   Alas2             11656          212            Aminolevulinic acid synthase 2, erythroid
  105.2858   1.6961    0.0049     0           ILMN_3161282   Dpysl5            65254          56896          Dihydropyrimidinase-like 5
  104.9667   1.6801    0.005      0           ILMN_1216452   Hbb-b1            NA             NA             NA
  101.7441   1.677     0.0048     0           ILMN_2735184   Col18a1           12822          80781          Collagen, type XVIII, alpha 1
  165.7567   1.6719    0.0137     1.00E-04    ILMN_1241293   Cldn5             12741          7122           Claudin 5
  104.234    1.67      0.0051     0           ILMN_2991389   Ly6g6e            70274          NA             Lymphocyte antigen 6 complex, locus G6E
  109.9056   1.6629    0.006      0           ILMN_3105563   Dmkn              73712          93099          Dermokine
  100.5225   1.6611    0.0046     0           ILMN_1259039   Sox8              NA             NA             NA
  119.8152   1.6562    0.0082     0           ILMN_1236718   Hbb-b1            NA             NA             NA
  107.4491   1.6543    0.005      0           ILMN_1234698   Tspan2            70747          10100          Tetraspanin 2
  114.2191   1.651     0.0071     0           ILMN_2457585   Trp53inp2         68728          58476          Transformation-related protein 53-inducible nuclear protein 2
  127.672    1.6497    0.0091     0           ILMN_2977558   Dapk2             13143          23604          Death-associated protein kinase 2
  115.4908   1.6484    0.0078     0           ILMN_2777359   Serpinh1          12406          871            Serine (or cysteine) peptidase inhibitor, clade H, member 1
  133.2106   1.6468    0.009      0           ILMN_2757125   Prc1              233406         9055           Protein regulator of cytokinesis 1
  168.1391   1.645     0.0138     1.00E-04    ILMN_2440194   5330423I11Rik     NA             NA             NA
  133.3424   1.6326    0.0088     0           ILMN_2903945   Gadd45g           23882          10912          Growth arrest and DNA-damage-inducible 45 gamma
  237.4537   1.6307    0.0286     2.00E-04    ILMN_3159435   Mid1              17318          NA             Midline 1
  121.1858   1.6264    0.0083     0           ILMN_2598103   Emp2              13731          2013           Epithelial membrane protein 2
  129.3051   1.6258    0.0091     0           ILMN_1215632   Marcksl1          17357          65108          MARCKS-like 1
  132.4496   1.6257    0.0091     0           ILMN_3144289   Traf3             22031          7187           TNF receptor-associated factor 3
  139.3631   1.6219    0.0092     0           ILMN_2675000   4930511J11Rik     74720          283953         Claudin 26
  125.9      1.6217    0.0091     0           ILMN_2439638   Traf3             22031          7187           TNF receptor-associated factor 3
  264.9656   1.6146    0.0379     2.00E-04    ILMN_2623983   Egr2              13654          1959           Early growth response 2
  167.9258   1.6117    0.0141     1.00E-04    ILMN_2506428   Ky                16716          339855         Kyphoscoliosis peptidase
  149.169    1.6067    0.0109     0           ILMN_2545963   Hbb-b1            NA             NA             NA
  147.5637   1.6053    0.0108     0           ILMN_2769490   5430435G22Rik     226421         338382         RIKEN cDNA 5430435G22 gene
  216.6505   1.6037    0.0234     1.00E-04    ILMN_2443330   Ttr               22139          7276           Transthyretin
  147.9521   1.6023    0.0111     0           ILMN_2467151   Cyp11a1           NA             NA             NA
  177.2045   1.6005    0.0155     1.00E-04    ILMN_1245549   6330404C01Rik     80982          57214          Cell migration inducing protein, hyaluronan binding
  156.4386   1.5987    0.0116     0           ILMN_1235571   Cyr61             16007          3491           Cysteine-rich protein 61
  151.0446   1.5966    0.0108     0           ILMN_2784078   Mmp15             17388          4324           Matrix metallopeptidase 15
  128.5692   1.592     0.0091     0           ILMN_1234099   Fermt1            241639         55612          Fermitin family homolog 1 (*Drosophila*)
  153.0722   1.591     0.0109     0           ILMN_2701891   Marcksl1          17357          65108          MARCKS-like 1
  169.069    1.5888    0.0138     1.00E-04    ILMN_1255462   Hbb-b1            NA             NA             NA
  238.1918   1.5774    0.0283     2.00E-04    ILMN_2750515   Fos               14281          2353           FBJ osteosarcoma oncogene
  179.4286   1.5767    0.0157     1.00E-04    ILMN_1258028   Gal3st1           53897          9514           Galactose-3-O-sulfotransferase 1
  168.0194   1.5754    0.0139     1.00E-04    ILMN_2621544   2700060E02Rik     18074          22795          Nidogen 2
  179.1935   1.5706    0.0159     1.00E-04    ILMN_2711163   Ctsk              13038          1513           Cathepsin K
  203.9522   1.5702    0.021      1.00E-04    ILMN_2965660   Apcdd1            494504         147495         Adenomatosis polyposis coli downregulated 1
  186.0794   1.5661    0.0162     1.00E-04    ILMN_2778722   Ppapdc1a          381925         196051         Phosphatidic acid phosphatase type 2 domain containing 1A
  183.6942   1.5565    0.0158     1.00E-04    ILMN_1246139   Cldn11            18417          5010           Claudin 11
  183.6736   1.5551    0.0161     1.00E-04    ILMN_2838308   Fmo1              14261          2326           Flavin-containing monooxygenase 1
  209.5265   1.5551    0.0219     1.00E-04    ILMN_2769777   Msc               17681          9242           Musculin
  256.1212   1.5496    0.0346     2.00E-04    ILMN_2703138   Tmem125           230678         128218         Transmembrane protein 125
  204.0502   1.5465    0.0207     1.00E-04    ILMN_2623184   Nkiras2           71966          28511          NF-κB inhibitor interacting Ras-like protein 2
  202.9992   1.5454    0.0207     1.00E-04    ILMN_2650447   Col23a1           237759         91522          Collagen, type XXIII, alpha 1
  215.8733   1.545     0.0231     1.00E-04    ILMN_1239117   Hbb-b1            NA             NA             NA
  221.9056   1.5432    0.0251     1.00E-04    ILMN_2638473   1190003M12Rik     68888          NA             Gastrokine 3
  202.5197   1.5425    0.0208     1.00E-04    ILMN_2753342   Hapln1            12950          1404           Hyaluronan and proteoglycan link protein 1
  210.5965   1.5409    0.022      1.00E-04    ILMN_2759371   Fgfbp1            14181          9982           Fibroblast growth factor binding protein 1
  235.9454   1.5331    0.0284     2.00E-04    ILMN_3097381   Mobp              17433          4336           Myelin-associated oligodendrocytic basic protein
  217.9308   1.5305    0.0236     1.00E-04    ILMN_2909782   Rras2             66922          22800          Related RAS viral (r-ras) oncogene homolog 2
  229.1399   1.5299    0.0263     1.00E-04    ILMN_2472451   Traf4             22032          9618           TNF receptor-associated factor 4
  271.8732   1.5286    0.0398     2.00E-04    ILMN_3162060   EG574403          574403         100131897      Family with sequence similarity 196, member B
  233.6047   1.5221    0.0277     2.00E-04    ILMN_2747923   Slc40a1           53945          30061          Solute carrier family 40 (iron-regulated transporter), member 1
  227.3295   1.5175    0.0263     1.00E-04    ILMN_2517041   Uhrf1             18140          29128          Ubiquitin-like, containing PHD and RING finger domains, 1
  280.3468   1.5086    0.0429     3.00E-04    ILMN_1241168   Dok4              114255         55715          Docking protein 4
  254.0057   1.5079    0.0341     2.00E-04    ILMN_2625854   2310016C16Rik     69590          493869         Glutathione peroxidase 8 (putative)
  256.2349   1.5077    0.0342     2.00E-04    ILMN_1229726   Fibcd1            98970          84929          Fibrinogen C domain containing 1
  304.0763   1.5074    0.0497     3.00E-04    ILMN_2522884   9930105H17Rik     NA             NA             NA
  270.2753   1.5045    0.0393     2.00E-04    ILMN_2815506   Gamt              14431          2593           Guanidinoacetate methyltransferase
  262.3132   1.5016    0.0369     2.00E-04    ILMN_2778111   Etv4              18612          2118           ets variant 4
  288.425    1.4979    0.0449     3.00E-04    ILMN_2604224   Sema5a            20356          9037           Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
  268.7263   1.4966    0.039      2.00E-04    ILMN_2688236   Atp2a3            53313          489            ATPase, Ca++ transporting, ubiquitous
  284.2455   1.4958    0.044      3.00E-04    ILMN_1236788   Igfbp2            16008          3485           Insulin-like growth factor-binding protein 2
  287.3425   1.492     0.0451     3.00E-04    ILMN_2737479   Slc12a9           83704          56996          Solute carrier family 12 (potassium/chloride transporters), member 9
  274.5651   1.4905    0.041      3.00E-04    ILMN_1257097   Cnp               12799          1267           2\',3\'-cyclic nucleotide 3\' phosphodiesterase
  288.7593   1.4897    0.0446     3.00E-04    ILMN_1219025   9030409G11Rik     71529          23254          Kazrin, periplakin interacting protein
  297.6994   1.4891    0.0481     3.00E-04    ILMN_1251524   Them4             75778          117145         Thioesterase superfamily member 4
  303.8564   1.4877    0.0501     3.00E-04    ILMN_1226329   Cd93              17064          22918          CD93 antigen
  305.5889   1.4821    0.0492     3.00E-04    ILMN_3126277   Palmd             114301         54873          Palmdelphin
  299.226    1.4801    0.0486     3.00E-04    ILMN_2655204   Apc               11789          324            Adenomatosis polyposis coli
  303.6034   1.4788    0.0505     3.00E-04    ILMN_2726030   AB023957          NA             NA             NA
  304.1851   1.476     0.0493     3.00E-04    ILMN_2772155   LOC100045780      11492          8728           A disintegrin and metallopeptidase domain 19 (meltrin beta)
  326.2746   −1.5473   0.0492     4.00E-04    ILMN_2939681   Lyzs              17110          4069           Lysozyme 1
  324.3234   −1.5513   0.0485     4.00E-04    ILMN_2718266   Fkbp5             14229          2289           FK506 binding protein 5
  300.7726   −1.5755   0.0398     3.00E-04    ILMN_2775885   Calm2             12314          NA             Calmodulin 2
  278.2959   −1.5868   0.0343     2.00E-04    ILMN_1224363   Slc12a5           57138          57468          Solute carrier family 12, member 5
  281.5906   −1.6113   0.0347     3.00E-04    ILMN_1251998   Gm765             330390         NA             Predicted gene 765
  226.9486   −1.6145   0.0249     1.00E-04    ILMN_2488510   Ppm1k             243382         152926         Protein phosphatase 1K (PP2C domain containing)
  308.258    −1.6168   0.0431     3.00E-04    ILMN_1248368   Mat2a             232087         4144           Methionine adenosyltransferase II, alpha
  275.8602   −1.6184   0.0343     2.00E-04    ILMN_2669088   4930461P20Rik     78244          134218         DNAJ (Hsp40) homolog, subfamily C, member 21
  253.8942   −1.62     0.0298     2.00E-04    ILMN_2435835   Evpl              14027          2125           Envoplakin
  197.6328   −1.6297   0.0211     1.00E-04    ILMN_2602387   Nr1d2             353187         9975           Nuclear receptor subfamily 1, group D, member 2
  311.5841   −1.6329   0.0428     3.00E-04    ILMN_2734000   Elavl4            15572          1996           ELAV (embryonic lethal, abnormal vision, *Drosophila*)-like 4 (Hu antigen D)
  311.1495   −1.6404   0.043      3.00E-04    ILMN_2859032   Gfod1             328232         54438          Glucose-fructose oxidoreductase domain containing 1
  253.0893   −1.6455   0.0299     2.00E-04    ILMN_2445958   Tssc8             63830          NA             KCNQ1 overlapping transcript 1
  258.1943   −1.6504   0.0299     2.00E-04    ILMN_2419660   mtDNA_ND4L        NA             NA             NA
  215.9199   −1.6523   0.0237     1.00E-04    ILMN_1221817   Cd74              16149          972            CD74 antigen (invariant polypeptide of MHC, class II antigen-associated)
  308.2304   −1.6595   0.0434     3.00E-04    ILMN_2545149   Nos1ap            70729          NA             Nitric oxide synthase 1 (neuronal) adaptor protein
  256.5251   −1.6631   0.0294     2.00E-04    ILMN_1219573   C130072A16Rik     105727         81539          Solute carrier family 38, member 1
  292.3656   −1.6664   0.0367     3.00E-04    ILMN_2475376   BC044804          NA             NA             NA
  229.2861   −1.6683   0.0251     1.00E-04    ILMN_1253544   2900060B14Rik     68204          NA             RIKEN cDNA 2900060B14 gene
  318.4001   −1.6694   0.0454     4.00E-04    ILMN_1246494   LOC381445         26422          26960          Neurobeachin
  282.6027   −1.6717   0.0345     3.00E-04    ILMN_2666980   BDNF              12064          627            BDNF
  219.961    −1.6722   0.0236     1.00E-04    ILMN_1231445   Inmt              21743          11185          Indolethylamine N-methyltransferase
  240.372    −1.6762   0.0269     2.00E-04    ILMN_1240202   Fnip1             216742         96459          Folliculin-interacting protein 1
  269.2034   −1.6764   0.033      2.00E-04    ILMN_2987863   Per2              18627          8864           Period circadian clock 2
  201.3209   −1.677    0.0212     1.00E-04    ILMN_3157692   Ankrd35           213121         148741         Ankyrin repeat domain 35
  310.3109   −1.679    0.0432     3.00E-04    ILMN_1218471   3-Sep             24050          55964          Septin 3
  229.1441   −1.6798   0.0254     1.00E-04    ILMN_1229216   Zbtb16            235320         7704           Zinc finger and BTB domain containing 16
  264.7303   −1.6841   0.0316     2.00E-04    ILMN_1253985   A330021D07Rik     NA             NA             NA
  171.7223   −1.6861   0.0163     1.00E-04    ILMN_1235966   Alox12b           11686          242            Arachidonate 12-lipoxygenase, 12R type
  253.9144   −1.6861   0.0295     2.00E-04    ILMN_1245687   Ash1l             192195         55870          ash1 (absent, small, or homeotic)-like (Drosophila)
  294.7856   −1.6875   0.0375     3.00E-04    ILMN_2674890   Tbl1x             21372          6907           Transducin (beta)-like 1 X-linked
  267.8862   −1.6889   0.0328     2.00E-04    ILMN_2828916   Frmd6             319710         122786         FERM domain containing 6
  254.4102   −1.6932   0.0293     2.00E-04    ILMN_1228077   6330437B22Rik     78283          256714         MAP7 domain containing 2
  282.4957   −1.6935   0.0347     3.00E-04    ILMN_2589525   Cpeb3             208922         22849          Cytoplasmic polyadenylation element binding protein 3
  277.0563   −1.6955   0.0345     2.00E-04    ILMN_2466121   Twistnb           28071          221830         TWIST neighbor
  250.5161   −1.6978   0.029      2.00E-04    ILMN_2514631   scl0002315.1_12   217869         1983           Eukaryotic translation initiation factor 5
  186.3783   −1.7007   0.0195     1.00E-04    ILMN_2493030   2310043N10Rik     66961          NA             Nuclear paraspeckle assembly transcript 1 (non-protein coding)
  263.9285   −1.7033   0.0315     2.00E-04    ILMN_2677270   Peg3              18616          5178           Paternally expressed 3
  239.6678   −1.7039   0.0271     2.00E-04    ILMN_1214405   Cnksr2            245684         22866          Connector enhancer of kinase suppressor of Ras 2
  253.7716   −1.7042   0.03       2.00E-04    ILMN_2763404   Nrxn3             18191          NA             Neurexin III
  182.2435   −1.7079   0.0186     1.00E-04    ILMN_1246861   Ctss              13040          1520           Cathepsin S
  278.7674   −1.7082   0.0341     2.00E-04    ILMN_1239608   Arid4a            238247         5926           AT-rich interactive domain 4A (RBP1-like)
  242.1379   −1.7088   0.0269     2.00E-04    ILMN_2745614   Fam134b           66270          54463          Family with sequence similarity 134, member B
  273.3035   −1.7094   0.0336     2.00E-04    ILMN_2762701   Scn1a             20265          6323           Sodium channel, voltage-gated, type I, alpha
  235.4555   −1.7097   0.0263     2.00E-04    ILMN_1243910   Zfp292            30046          23036          Zinc finger protein 292
  182.6041   −1.71     0.0184     1.00E-04    ILMN_2690603   Spp1              20750          6696           Secreted phosphoprotein 1
  262.6651   −1.7167   0.0313     2.00E-04    ILMN_2733314   Rgs7bp            52882          401190         Regulator of G-protein signaling 7 binding protein
  218.5161   −1.7173   0.0237     1.00E-04    ILMN_2593368   Mat2a             232087         4144           Methionine adenosyltransferase II, alpha
  248.3251   −1.7218   0.0284     2.00E-04    ILMN_2525034   Cc1               12421          9821           RB1-inducible coiled-coil 1
  244.6249   −1.7232   0.0273     2.00E-04    ILMN_2713008   C030011O14Rik     215708         374986         Family with sequence similarity 73, member A
  244.4499   −1.7244   0.0276     2.00E-04    ILMN_1228020   1500010G04Rik     NA             NA             NA
  214.8649   −1.7247   0.0242     1.00E-04    ILMN_2664706   Chic1             12212          53344          Cysteine-rich hydrophobic domain 1
  224.3588   −1.7256   0.0252     1.00E-04    ILMN_1251488   A430041B07Rik     328108         23116          Family with sequence similarity 179, member B
  167.7266   −1.7283   0.0158     1.00E-04    ILMN_2651054   LOC100047173      269589         84958          Synaptotagmin-like 1
  233.1724   −1.7313   0.0262     2.00E-04    ILMN_2713004   C030011O14Rik     215708         374986         Family with sequence similarity 73, member A
  224.4289   −1.7346   0.0249     1.00E-04    ILMN_1233554   Pbrm1             66923          55193          Polybromo 1
  215.0498   −1.7355   0.0239     1.00E-04    ILMN_2669461   Bbx               70508          56987          Bobby sox homolog (*Drosophila*)
  220.6021   −1.7382   0.0238     1.00E-04    ILMN_1218712   Jph4              NA             NA             NA
  229.662    −1.7394   0.0248     1.00E-04    ILMN_1231596   Mtap7             NA             NA             NA
  217.0292   −1.7397   0.0237     1.00E-04    ILMN_2492395   2900064A13Rik     NA             NA             NA
  194.6882   −1.7416   0.0213     1.00E-04    ILMN_1218051   Iqgap2            544963         10788          IQ motif containing GTPase activating protein 2
  224.9623   −1.7422   0.0249     1.00E-04    ILMN_1220626   2010007K12Rik     NA             NA             NA
  193.5535   −1.7437   0.0213     1.00E-04    ILMN_2689307   Spnb2             20742          6711           Spectrin β, non-erythrocytic 1
  211.5491   −1.7446   0.0235     1.00E-04    ILMN_2594593   Mpp5              56217          64398          Membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
  196.6783   −1.7461   0.0214     1.00E-04    ILMN_2541675   LOC382128         319675         85459          RIKEN cDNA 5830418K08 gene
  225.9716   −1.7473   0.0251     1.00E-04    ILMN_1230605   Gm336             212285         116984         ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
  172.8921   −1.7587   0.0162     1.00E-04    ILMN_2803674   S100a9            20202          6280           S100 calcium binding protein A9 (calgranulin B)
  192.6629   −1.759    0.0213     1.00E-04    ILMN_3072536   Eif5              217869         1983           Eukaryotic translation initiation factor 5
  138.7531   −1.7606   0.0112     0           ILMN_1255416   Ly6a              110454         NA             Lymphocyte antigen 6 complex, locus A
  206.7346   −1.7624   0.0217     1.00E-04    ILMN_2596077   2810474O19Rik     67246          55196          RIKEN cDNA 2810474O19 gene
  190.8274   −1.7627   0.0211     1.00E-04    ILMN_1237335   A730028C12Rik     NA             NA             NA
  197.1239   −1.7662   0.0214     1.00E-04    ILMN_2593230   Mllt4             17356          4301           Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
  200.8213   −1.769    0.0212     1.00E-04    ILMN_2595282   2600005C20Rik     72462          23076          Ribosomal RNA processing 1 homolog B (S. cerevisiae)
  200.7106   −1.7702   0.0215     1.00E-04    ILMN_2481389   Zfp326            54367          284695         Zinc finger protein 326
  164.0235   −1.774    0.0155     1.00E-04    ILMN_1220828   2900075B16Rik     78506          286097         Mitochondrial calcium uptake family, member 3
  155.2155   −1.7756   0.0142     0           ILMN_2571934   D030034I04Rik     105727         81539          Solute carrier family 38, member 1
  176.004    −1.7781   0.0166     1.00E-04    ILMN_1229727   Gpr123            52389          84435          G-protein-coupled receptor 123
  175.0744   −1.7835   0.0164     1.00E-04    ILMN_1237059   Kcna1             16485          3736           Potassium voltage-gated channel, shaker-related subfamily, member 1
  152.5807   −1.7867   0.014      0           ILMN_2512204   mt-Nd4l           NA             NA             NA
  191.3641   −1.7915   0.021      1.00E-04    ILMN_1236941   Csnk2a1-rs3       12995          1457           Casein kinase 2, alpha 1 polypeptide
  117.9399   −1.796    0.0095     0           ILMN_2629112   Asah3l            230379         340485         Alkaline ceramidase 2
  154.7781   −1.7976   0.0144     0           ILMN_2423249   2010321I05Rik     233833         27327          Trinucleotide repeat containing 6a
  169.376    −1.7979   0.0157     1.00E-04    ILMN_1260446   Ttc3              22129          7267           Tetratricopeptide repeat domain 3
  159.9385   −1.8005   0.0148     0           ILMN_3151492   Ankrd12           106585         23253          ankyrin repeat domain 12
  159.7083   −1.8008   0.0149     0           ILMN_2747381   Ddx24             27225          57062          DEAD (Asp-Glu-Ala-Asp) box polypeptide 24
  117.7708   −1.806    0.0094     0           ILMN_2746797   Hsf4              26386          3299           Heat shock transcription factor 4
  154.9416   −1.8113   0.0141     0           ILMN_1227149   Meg3              17263          NA             Maternally expressed 3
  154.4618   −1.8188   0.0141     0           ILMN_2544603   2610015J01Rik     67039          NA             RNA binding motif protein 25
  149.6626   −1.8218   0.0137     0           ILMN_1234357   A230057E24Rik     NA             NA             NA
  160.7228   −1.8235   0.0145     0           ILMN_2737867   Mtap1b            17755          4131           Microtubule-associated protein 1B
  146.4398   −1.8285   0.0132     0           ILMN_2657911   Cnot4             53621          4850           CCR4-NOT transcription complex, subunit 4
  137.4716   −1.8312   0.0115     0           ILMN_2654932   Pdap1             231887         11333          PDGFA-associated protein 1
  149.0718   −1.8342   0.0133     0           ILMN_2542231   LOC382157         228005         9360           Peptidyl-prolyl isomerase G (cyclophilin G)
  136.8161   −1.8372   0.0118     0           ILMN_1256701   2900016B01Rik     74901          9920           Kelch repeat and BTB (POZ) domain containing 11
  140.2596   −1.8406   0.0112     0           ILMN_1217776   Mll5              69188          55904          Lysine (K)-specific methyltransferase 2E
  123.3913   −1.8632   0.0097     0           ILMN_2466797   scl0001284.1_18   NA             NA             NA
  120.66     −1.8657   0.0092     0           ILMN_2495555   Mapk8ip2          NA             NA             NA
  110.3349   −1.8716   0.008      0           ILMN_2720479   Lpgat1            226856         9926           Lysophosphatidylglycerol acyltransferase 1
  107.1799   −1.8815   0.0084     0           ILMN_3031781   Arid5b            71371          84159          AT-rich interactive domain 5B (MRF1-like)
  108.2637   −1.8822   0.0082     0           ILMN_2968123   Slc7a14           241919         57709          Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14
  102.8964   −1.8896   0.0082     0           ILMN_2524100   Zswim6            67263          57688          Zinc finger SWIM-type containing 6
  106.148    −1.8943   0.008      0           ILMN_1243996   Ash1l             192195         55870          ash1 (absent, small, or homeotic)-like (Drosophila)
  108.9677   −1.8986   0.0082     0           ILMN_1226085   Syt1              NA             NA             NA
  99.6837    −1.8993   0.0081     0           ILMN_2844963   Nos1ap            70729          NA             Nitric oxide synthase 1 (neuronal) adaptor protein
  80.4955    −1.9004   0.0043     0           ILMN_3107059   Espn              56226          83715          Espin
  150.8775   −1.9026   0.0136     0           ILMN_1245389   LOC236604         236604         NA             Phosphatidylserine decarboxylase, pseudogene 1
  99.2247    −1.9029   0.0085     0           ILMN_2715848   Slitrk4           245446         139065         SLIT and NTRK-like family, member 4
  104.8752   −1.9033   0.0083     0           ILMN_2771709   Ppargc1b          170826         133522         Peroxisome proliferative-activated receptor, γ, coactivator 1 β
  93.2724    −1.922    0.0076     0           ILMN_3028837   Pcdh9             211712         5101           Protocadherin 9
  70.0507    −1.9234   0.0043     0           ILMN_2752883   Hsp90aa1          15519          3320           Heat shock protein 90, alpha (cytosolic), class A member 1
  68.4948    −1.9249   0.0045     0           ILMN_2702303   Ch25h             12642          9023           Cholesterol 25-hydroxylase
  78.6377    −1.9335   0.0045     0           ILMN_3144164   Irs2              384783         8660           Insulin receptor substrate 2
  83.4984    −1.9539   0.005      0           ILMN_1255854   Mtap9             213582         79884          Microtubule-associated protein 9
  62.4352    −1.9916   0.0039     0           ILMN_2639442   Rock2             19878          9475           Rho-associated coiled-coil containing protein kinase 2
  65.2953    −2.006    0.0047     0           ILMN_2703913   Mtf2              17765          22823          Metal response element binding transcription factor 2
  57.2834    −2.0145   0.0018     0           ILMN_1236844   A830094I09Rik     NA             NA             NA
  55.3183    −2.0239   0.0021     0           ILMN_1236820   9430047F21Rik     NA             NA             NA
  55.866     −2.0392   0.0019     0           ILMN_2432200   Epb4.1            NA             NA             NA
  49.8425    −2.0396   0.0023     0           ILMN_2642426   Agmat             75986          79814          agmatine ureohydrolase (agmatinase)
  45.5522    −2.0743   0.0017     0           ILMN_1237548   5830407P18Rik     NA             NA             NA
  44.5367    −2.0756   0.0018     0           ILMN_1259747   Il33              77125          90865          Interleukin-33
  40.11      −2.0942   0.001      0           ILMN_3124885   Pdpk1             18607          5170           3-Phosphoinositide dependent protein kinase 1
  35.7678    −2.1106   0          0           ILMN_2601176   Meg3              17263          NA             Maternally expressed 3
  38.3554    −2.1249   0.0011     0           ILMN_1225423   Mslnl             328783         NA             Mesothelin-like
  55.718     −2.1295   0.002      0           ILMN_2668333   Prg4              96875          NA             Proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein)
  27.1219    −2.1716   0          0           ILMN_1216085   B230387C07Rik     106585         23253          Ankyrin repeat domain 12
  25.1926    −2.2119   0          0           ILMN_1238436   Cplx2             12890          10814          Complexin 2
  107.5742   −2.2202   0.0081     0           ILMN_2965669   Xlr4a             NA             NA             NA
  28.7047    −2.2624   0          0           ILMN_2661820   Agxt2l1           71760          64850          Ethanolamine phosphate phospholyase
  23.2317    −2.4004   0          0           ILMN_2652500   Lrg1              76905          116844         Leucine-rich alpha-2-glycoprotein 1
  11.5889    −2.5107   0          0           ILMN_1229990   Agxt2l1           71760          64850          Ethanolamine phosphate phospholyase
  14.3442    −2.7824   0          0           ILMN_2710905   S100a8            20201          6279           S100 calcium binding protein A8 (calgranulin A)
  3.6486     −3.7411   0          0           ILMN_2712075   Lcn2              16819          3934           Lipocalin 2

V1 transcriptomes were profiled with microarray from juvenile mice with naturally elevated experience-dependent plasticity to generate the juvenile plasticity differential expression signature. Using RankProd differential expression (DE) analysis, V1 of juvenile male mice C57BL/6 at P29 was compared to adult C57BL/6 mice (\>P60; *n* = 3 each group) to identify 248 DE probes, which mapped to 193 unique mouse Entrez IDs. For downstream analysis, mouse Entrez IDs were mapped to human orthologs using the Mouse Genome Informatics homology reference to yield a 176 gene juvenile plasticity signature. FC, fold change. RP, rank product. pfp, percent false positive (i.e. false discovery rate).

Disease Leverage Analysis (DLA) identifies inflammatory processes as putative disruptors of plasticity {#s4B}
------------------------------------------------------------------------------------------------------

We sought to identify shared pathophysiology across the diverse list of diseases predicted to dysregulate plasticity signatures. To do so, we developed DLA. This approach calculates the association between diseases that dysregulate the plasticity signature genes and the 50 gene sets in the hallmark library ([@B58]) that represent well defined and distinct biological pathways. Specifically, DLA computes a linear regression between the molecular match score (a measure of strength of association between disease and plasticity signatures) and the pathology score (a measure of activity of the biological pathway in a given disease). Large regression coefficients indicate that a given biological pathway is highly active in diseases that dysregulate plasticity gene signatures and may be pathological to developmental plasticity. Using a multiple test-corrected, empirical *p* value threshold of *p* \< 5 × 10^−5^, we found that 7 of 14 largest DLA associations were inflammation-related gene sets and that every inflammation-related gene set in the hallmark library was strongly associated with diseases that dysregulate the plasticity signature (7 of 7 inflammation gene sets at a threshold of *p*~corrected~ \< 5 × 10^−5^: OR = 25.8, 95% CI = 1.4--491.2, *p* = 2.7 × 10^−3^~a~, Fisher's exact test; [Figs. 1c](#F1){ref-type="fig"}, [1--1](#F2){ref-type="fig"}). Moreover, two of these gene sets, tumor necrosis factor-α (TNF-α) signaling via nuclear factor-κB (NF-κB) and interferon-γ (IFN-γ) response, reflect pathways involved in critical period plasticity ([@B29]; [@B46]).

![DLA identifies biological processes common to diseases that perturb the juvenile plasticity signature. To identify shared pathophysiology across the diverse list of diseases predicted to dysregulate the juvenile plasticity signature, we applied DLA. This approach calculates the association between diseases that dysregulate the plasticity signature genes and 50 well defined and distinct biological pathways. To do so, it computes a regression between the molecular match score (a measure that indicates the strength of association between the disease and plasticity signatures; see [Table 3](#T3){ref-type="table"} and Materials and Methods) and the pathology score (a measure of activity of the biological pathway in that disease; see Materials and Methods). Large regression coefficients indicate that the biological pathway may disrupt juvenile plasticity. Using a multiple test-corrected, empirical *p* \< 5 × 10^−5^, seven of the 14 largest DLA associations were inflammation-related gene sets, and every inflammation-related gene set in the hallmark library was strongly associated with diseases that dysregulate plasticity genes (seven of seven inflammation gene sets at *p*~corrected~ \< 5 × 10^−5^: OR = 25.8, 95% CI = 1.4--491.2, *p* = 2.7 × 10^−3^, Fisher's exact test). A total of 20,000 permutations of the gene sets was used to estimate *p* values and to normalize the regression coefficients to allow comparison between effect sizes for different biological pathways. Inflammation-related gene sets: TNF-α signaling via NF-κB, IFN-γ response, inflammatory response, complement, IL-2--Stat5 signaling, IFN-α response, IL-6--Jak--Stat3 signaling.](enu0061622030002){#F2}

To control for nonplasticity aspects of age, we repeated the entire analysis using a *Lynx1*^−/−^ plasticity signature of 98 genes, which was identified by computing the differential expression between adult *Lynx1*^−/−^ and adult wild-type V1 ([Table 4](#T4){ref-type="table"}). By releasing the *Lynx1* brake on plasticity, *Lynx1*^−/−^ mice have juvenile-like plasticity in adulthood ([@B43]; [@B7]). Indeed, functional similarity is reflected in signature similarity, as juvenile and *Lynx1*^−/−^ plasticity signatures significantly overlap (35 genes shared, OR = 37.1, 95% CI = 23.8--58.0, *p* \< 2.2 × 10^−16^~b~). Applying DLA to the *Lynx1*^−/−^ molecular matches, we found a strong association between diseases predicted to disrupt *Lynx1*^−/−^ plasticity and inflammation-related gene sets (7 of 7 inflammation gene sets at a threshold of *p*~corrected~ \< 5 × 10^−5^: OR = 63.0, 95% CI = 3.2--1229.8, *p* = 7.6 × 10^−5^~c~ Fisher's exact test; [Figs. 2](#F3){ref-type="fig"}, [2-1](#F4){ref-type="fig"}). Together, the bioinformatics analyses indicate that inflammation is a process central to diseases predicted to dysregulate plasticity gene expression, suggesting that inflammation may disrupt developmental plasticity.

![Diseases that dysregulate the adult *Lynx1*^−/−^ plasticity signature are associated with inflammatory processes. Using an adult *Lynx1*^−/−^ plasticity signature of 98 genes (generated by differential expression of primary visual cortex from \>P60 *Lynx1*^−/−^ vs \>P60 C57BL/6 male mice), DLA systematically identified biological processes associated with diseases that dysregulate the adult *Lynx1*^−/−^ plasticity signature genes. Using adult *Lynx1*^−/−^ animals controls for age, as these adult animals have elevated plasticity similar to that of juvenile animals. Seven of the 11 largest associations were inflammation-related gene sets, and every inflammation-related gene set was strongly associated with plasticity (7 of 7 inflammation gene sets at *p*~corrected~ \< 5 × 10^−5^: OR = 63.0, 95% CI = 3.2--1229.8, *p* = 7.6 × 10^−5^, Fisher's exact test). See [Figure 2-1](#F4){ref-type="fig"} for source DLA data.](enu0061622030003){#F3}

![DLA identifies biological processes common to diseases that perturb the *Lynx1*^−/−^ plasticity signature. To identify shared pathophysiology across the diverse list of diseases predicted to dysregulate the *Lynx1*^−/−^ plasticity signature, we applied DLA. Large regression coefficients indicate that the biological pathway may disrupt *Lynx1*^−/−^ plasticity. As with the juvenile plasticity signature, using a multiple test-corrected, empirical *p* \< 5 × 10^−5^, we found that every inflammation-related gene set in the hallmark library was strongly associated with diseases that dysregulate plasticity genes (7 of 7 inflammation gene sets at *p*~corrected~ \< 5 × 10^−5^: OR = 63.0, 95% CI = 3.2--1229.8, *p* = 7.6 × 10^−5^ Fisher's exact test). A total of 20,000 permutations of the gene sets were used to estimate *p* values and to normalize the regression coefficients to allow comparison between effect sizes for different biological pathways. Inflammation-related gene sets: TNF-α signaling via NF-κB, IFN-γ response, inflammatory response, complement, IL-2--Stat5 signaling, IFN-α response, IL-6--Jak--Stat3 signaling.](enu0061622030004){#F4}

Lipopolysaccharide model of inflammation suppresses developmental cortical plasticity {#s4C}
-------------------------------------------------------------------------------------

Based on the DLA findings, we hypothesized that inflammatory processes disrupt developmental cortical plasticity. To test this hypothesis, we induced a systemic inflammatory response via LPS and measured the impact on developmental plasticity and related gene expression. We injected a low dose of LPS (300 μg/kg, intraperitoneal) at the peak of juvenile ocular dominance plasticity at P26 and found a strong inflammatory response in V1, as indicated by a 2.4 log~2~ fold increase of interleukin (IL)-1β compared with vehicle control (*p* = 3.4 × 10^−4^~d~, *t* test of Δ CTs, *n* = 5 mice/group). To identify a focused subset of plasticity genes likely to be regulated by LPS (regardless of age or specific brain region) to test *in vivo*, we investigated a highly significant molecular match between the juvenile plasticity signature and an adult brain-derived LPS transcriptome (GSE3253; rank \#14, *p* = 7.9 × 10^−4^~e~; empirical *p* value calculated using molecular match algorithm; [Fig. 3a](#F5){ref-type="fig"}; [Table 3](#T3){ref-type="table"}). Next, we identified a subset of genes from GSE3253 that is likely to play a larger role in the under-lying biology (the genes in the extremes using a *z*-score cutoff) and intersected it with the plasticity signature to identify 16 shared genes ([Fig. 3b](#F5){ref-type="fig"}). Notably, among these shared genes, we identified a negative correlation in their expression pattern (cor = −0.77, *p* = 0.0007~f~, Spearman's correlation). Among these 16 shared genes, the adult LPS data indicated the direction of expression of 13 genes would be reversed by LPS. Indeed, the majority (61.5%) of the 13 genes showed a complete reversal in their differential expression pattern in V1 after peripheral LPS administration during the critical period (qPCR, all reversed genes *p* \< 5 × 10^−4^~g~, *t* test of Δ CTs, *n* = 5 mice per group; [Fig. 3c](#F5){ref-type="fig"}). These data indicate that genes in the plasticity signature that are also regulated by LPS act in an antagonistic fashion and naturally led us to the hypothesis that inflammation may suppress plasticity. Consistent with this logic, the established brakes of plasticity, *PirB* ([@B59]) and *H2K1* and *H2D1* ([@B11]), showed increased expression compared with vehicle (*p* = 0.04~h~ and *p* = 0.03~i~, respectively, *t* test of Δ CTs, *n* = 5 mice per group; [Fig. 4a,b](#F6){ref-type="fig"}). In addition, a trigger of plasticity that increases across development, BDNF ([@B26]), which we predicted *in silico* to decrease after LPS ([Fig. 3b](#F5){ref-type="fig"}), showed decreased expression compared with vehicle (*p* = 0.009~j~, *t* test of ΔCTs, *n* = 5 mice/group; [Fig. 4b](#F6){ref-type="fig"}). In contrast, other known plasticity effectors ([@B60]) were not changed relative to vehicle (*Nptx2*, *Lynx1*, *NogoR*, *Ppp3ca*; *p* \> 0.1~k~, *t* test of Δ CTs, *n* = 5 mice per group), indicating that LPS may act through a specific subset of known and novel plasticity effectors ([Fig. 4b](#F6){ref-type="fig"}).

![LPS reverses plasticity signature gene expression. ***a***, LPS disease signature shares plasticity signature genes *in silico* (molecular match rank \#14, *p* = 7.9 × 10^−4^; [Table 3](#T3){ref-type="table"}; disease signature is from GSE3253: adult mouse whole-brain homogenate harvested 4 h after peripheral LPS injected intraperitoneally; genes with absolute value of the standardized expression (*z*-score) ≥2 SDs from the mean were selected as the most differentially expressed by LPS). ***b***, The expression of the 16 genes shared between juvenile plasticity and the LPS disease signatures is anticorrelated (Spearman's ρ = −0.77, *p* = 7.4 × 10^−4^; LPS disease signature gene expression values fell in the range \[−1,+1\]; for plotting purposes, the plasticity gene expression fold change was linear transformed to \[−1,+1\]). ***c***, Of the 13 genes of the 16 predicted to be reversed by LPS, the majority (8 of 13; 61.5%) showed a complete reversal in their differential expression pattern in V1 after LPS administration (300 μg/kg LPS, intraperitoneally, at P26 during the peak of juvenile plasticity) relative to saline. LPS downregulated *Cldn5* and *Slc40a1* and upregulated *Alox12b*, *S100a9a*, *Ch25h*, *Lrg1*, *S100a8*, and *Lcn2* (*n* = 5 mice per group). \*\*\**p* \< 0.001, \*\**p* \> 0.001 and ≤0.01, \**p* \> 0.01 and ≤0.05 (two-sided *t* tests of ΔCTs). Log2 fold change is −ΔΔ CT. Error bars indicate the SEM.](enu0061622030005){#F5}

###### 

Molecular matching among 436 disease signatures and the juvenile plasticity signature indicates diverse diseases may disrupt plasticity

  Rank   Normalized molecular match score   Emp_pval   FDR        Source_dat       Species               Disease                                                                                    Tissue
  ------ ---------------------------------- ---------- ---------- ---------------- --------------------- ------------------------------------------------------------------------------------------ --------------------------------------------------------------
  1      9.64                               4.53E-08   1.22E-05   GSE7958          *Mus musculus*        Huntington\'s disease                                                                      CNS, brain, striatum (MMHCC)
  2      8.35                               7.74E-08   1.22E-05   GSE1623          *Mus musculus*        Type 1 diabetes mellitus                                                                   Pancreas
  3      8.32                               8.58E-07   3.40E-05   GSE9857          *Mus musculus*        Huntington\'s disease                                                                      CNS, brain, striatum (MMHCC)
  4      7.96                               1.38E-07   1.22E-05   GSE4648          *Mus musculus*        Acute myocardial infarction                                                                Myocardial tissue
  5      7.59                               1.40E-07   1.22E-05   GSE4290          *Homo sapiens*        Glioblastoma                                                                               CNS, brain (MMHCC)
  6      7.52                               3.36E-07   2.44E-05   GSE1481          *Homo sapiens*        Anterior horn cell disease                                                                 CNS, spinal cord (MMHCC)
  7      6.81                               9.04E-08   1.22E-05   GSE2240          *Homo sapiens*        Atrial fibrillation                                                                        Myocardial tissue
  8      6.73                               1.47E-06   4.94E-05   GSE5500          *Mus musculus*        Cardiac hypertrophy                                                                        Myocardial tissue
  9      6.47                               8.10E-07   3.40E-05   GSE5389          *Homo sapiens*        Bipolar disorder                                                                           frontal cortex
  10     6.33                               8.15E-07   3.40E-05   GSE5078          *Mus musculus*        Senescence                                                                                 Hippocampus
  11     6.25                               1.75E-06   5.46E-05   GSE4764          *Mus musculus*        *Yersinia enterocolitica* food poisoning                                                   Peyer\'s patch
  12     5.75                               7.82E-07   3.40E-05   GSE4290          *Homo sapiens*        Astrocytoma                                                                                CNS, brain (MMHCC)
  13     5.7                                1.73E-05   3.59E-04   GSE1621          *Mus musculus*        Cardiac hypertrophy                                                                        Myocardial tissue
  14     5.67                               6.55E-05   7.88E-04   GSE3253          *Mus musculus*        Bacterial infection                                                                        CNS, brain (MMHCC)
  15     5.61                               1.16E-06   4.22E-05   GSE10599         *Mus musculus*        Spinal muscular atrophy                                                                    Kidney
  16     5.55                               2.49E-06   7.25E-05   GSE3744          *Homo sapiens*        Breast cancer                                                                              Mammary gland tissue
  17     5.43                               1.32E-05   3.04E-04   GSE6731          *Homo sapiens*        Crohn\'s disease                                                                           Intestine, large intestine, colon (MMHCC)
  18     5.38                               2.24E-05   4.24E-04   GSE6731          *Homo sapiens*        Ulcerative colitis                                                                         Intestine, large intestine, colon (MMHCC)
  19     5.35                               1.29E-05   3.04E-04   GSE11343         *Mus musculus*        Diabetic neuropathy                                                                        Sciatic nerve
  20     5.35                               7.33E-07   3.40E-05   GSE4316          *Homo sapiens*        Primary open angle glaucoma                                                                Trabecular meshwork
  21     5.28                               2.67E-05   4.65E-04   GSE5406          *Homo sapiens*        Cardiomyopathy                                                                             Myocardial tissue
  22     5.02                               3.36E-05   5.29E-04   GSE464           *Rattus norvegicus*   Spinal cord injury                                                                         CNS, spinal cord (MMHCC)
  23     4.98                               1.87E-05   3.71E-04   EXPE-MEXP-567    *Homo sapiens*        Glioblastoma                                                                               Brain
  24     4.94                               1.17E-04   1.13E-03   GSE1025          *Mus musculus*        DMD                                                                                        Muscle, striated (skeletal) (MMHCC)
  25     4.9                                5.26E-05   6.95E-04   GSE1843          *Rattus norvegicus*   Hepatic cirrhosis                                                                          Hepatic tissue
  26     4.86                               1.54E-05   3.37E-04   GSE1572          *Homo sapiens*        Senescence                                                                                 frontal cortex
  27     4.81                               6.87E-05   7.88E-04   GSE1472          *Mus musculus*        DMD                                                                                        Muscle, striated (skeletal) (MMHCC)
  28     4.81                               9.47E-06   2.43E-04   GSE2510          *Homo sapiens*        Obesity                                                                                    Adipocyte
  29     4.8                                3.91E-05   5.49E-04   GSE3383          *Mus musculus*        Cardiac hypertrophy                                                                        Myocardial tissue
  30     4.78                               1.06E-04   1.05E-03   GSE1629          *Homo sapiens*        Dental cavity, complex                                                                     Dental pulp
  31     4.72                               6.79E-05   7.88E-04   GSE2629          *Mus musculus*        Muscular dystrophy                                                                         Muscle, striated (skeletal) (MMHCC)
  32     4.67                               3.90E-05   5.49E-04   GSE4290          *Homo sapiens*        Oligodendroglioma                                                                          CNS, brain (MMHCC)
  33     4.63                               1.71E-04   1.49E-03   GSE10760         *Homo sapiens*        Muscular dystrophy                                                                         Musculus vastus lateralis
  34     4.62                               9.53E-05   1.01E-03   GSE1988          *Mus musculus*        Cardiac failure                                                                            Myocardial tissue
  35     4.61                               4.84E-05   6.59E-04   GSE3467          *Homo sapiens*        Papillary carcinoma of the thyroid                                                         Thyroid gland (MMHCC)
  36     4.57                               3.84E-05   5.49E-04   GSE3621          *Mus musculus*        Huntington\'s disease                                                                      Brain
  37     4.56                               3.35E-05   5.29E-04   GSE4107          *Homo sapiens*        Cancer of colon                                                                            Intestine, large intestine, colon (MMHCC)
  38     4.54                               1.20E-04   1.14E-03   GSE842           *Mus musculus*        MS                                                                                         CNS, spinal cord (MMHCC)
  39     4.53                               8.18E-05   9.14E-04   GSE14905         *Homo sapiens*        Psoriasis vulgaris                                                                         Skin tissue
  40     4.51                               3.40E-05   5.29E-04   GSE7305          *Homo sapiens*        Endometriosis                                                                              Endometrium
  41     4.48                               8.91E-06   2.43E-04   GSE16524         *Homo sapiens*        Setleis syndrome                                                                           Skin fibroblast
  42     4.46                               6.85E-05   7.88E-04   GSE4183          *Homo sapiens*        Carcinoma *in situ* of large intestine                                                     Colon
  43     4.43                               2.37E-05   4.30E-04   GSE12654         *Homo sapiens*        Schizophrenia                                                                              Cerebral cortex
  44     4.3                                1.62E-04   1.44E-03   GSE2866          *Mus musculus*        γ-Hydroxybutyric acidemia                                                                  CNS, brain, cerebellum (MMHCC)
  45     4.22                               9.23E-05   1.01E-03   GSE1859          *Mus musculus*        FDIU                                                                                       Hepatic tissue
  46     4.19                               5.52E-05   7.08E-04   GSE4587          *Homo sapiens*        Malignant melanoma                                                                         Epidermis
  47     4.16                               2.13E-04   1.82E-03   GSE63            *Mus musculus*        Cerebral infarction                                                                        CNS, brain (MMHCC)
  48     4.16                               2.26E-04   1.83E-03   GSE6614          *Mus musculus*        Generalized seizures                                                                       Brain
  49     4.08                               1.58E-04   1.44E-03   GSE6280          *Homo sapiens*        Chronic kidney disease                                                                     Kidney
  50     4.01                               3.19E-04   2.44E-03   GSE5390          *Homo sapiens*        Down's syndrome                                                                            Brain
  51     4.01                               2.66E-04   2.11E-03   GSE2052          *Homo sapiens*        Idiopathic fibrosing alveolitis                                                            Lung tissue
  52     4                                  2.23E-04   1.83E-03   GSE1873          *Mus musculus*        Obstructive sleep apnea                                                                    Hepatic tissue
  53     3.97                               4.39E-04   3.07E-03   GSE4183          *Homo sapiens*        IBD                                                                                        Colon
  54     3.96                               1.01E-04   1.02E-03   GSE3075          *Mus musculus*        Spinal muscular atrophy, infantile                                                         CNS, spinal cord (MMHCC)
  55     3.94                               1.42E-04   1.32E-03   GSE3167          *Homo sapiens*        Urothelial carcinoma *in situ*                                                             Urothelium
  56     3.93                               2.20E-04   1.83E-03   GSE8514          *Homo sapiens*        Adenoma                                                                                    Adrenal gland
  57     3.93                               4.01E-04   2.92E-03   GSE6764          *Homo sapiens*        Carcinoma, hepatocellular                                                                  Liver
  58     3.92                               4.89E-04   3.18E-03   GSE3585          *Homo sapiens*        Cardiomyopathy, dilated                                                                    Myocardial tissue
  59     3.89                               3.39E-04   2.55E-03   GSE1420          *Homo sapiens*        Barrett esophagus                                                                          Esophageal tissue
  60     3.88                               9.89E-05   1.02E-03   GSE1420          *Homo sapiens*        Adenocarcinoma of esophagus                                                                Esophageal tissue
  61     3.87                               4.40E-04   3.07E-03   GSE781           *Homo sapiens*        Clear cell carcinoma of kidney                                                             Renal tissue
  62     3.87                               5.95E-04   3.51E-03   GSE2528          *Mus musculus*        Breast cancer                                                                              Mammary gland
  63     3.84                               9.37E-04   4.92E-03   GSE1026          *Mus musculus*        DMD                                                                                        Muscle, striated (skeletal), diaphragm (MMHCC)
  64     3.79                               5.25E-04   3.35E-03   GSE3678          *Homo sapiens*        Papillary carcinoma of the thyroid                                                         Thyroid gland (MMHCC)
  65     3.74                               4.88E-04   3.18E-03   GSE4619          *Homo sapiens*        MDS                                                                                        Bone marrow stem cell
  66     3.73                               5.92E-04   3.51E-03   GSE3112          *Homo sapiens*        Polymyositis                                                                               Muscle tissue
  67     3.72                               3.51E-04   2.59E-03   GSE3189          *Homo sapiens*        Multiple benign melanocytic nevi                                                           Epidermis
  68     3.68                               5.76E-04   3.49E-03   GSE769           *Mus musculus*        Cystic fibrosis                                                                            Pancreas
  69     3.66                               5.76E-04   3.49E-03   GSE10432         *Homo sapiens*        Acne                                                                                       Sebocyte
  70     3.65                               1.30E-03   6.16E-03   GSE3252          *Mus musculus*        Muscular dystrophy                                                                         Muscle, striated (skeletal), diaphragm (MMHCC)
  71     3.62                               4.81E-04   3.18E-03   GSE12649         *Homo sapiens*        Schizophrenia                                                                              Cerebral cortex
  72     3.6                                7.41E-04   4.17E-03   GSE2501          *Mus musculus*        Thymic carcinoma                                                                           Thymus
  73     3.59                               1.20E-03   5.87E-03   GSE3268          *Homo sapiens*        Squamous cell carcinoma of lung                                                            Lung tissue
  74     3.58                               7.82E-04   4.32E-03   GSE857           *Mus musculus*        Huntington\'s disease                                                                      CNS, brain (MMHCC)
  75     3.58                               2.96E-04   2.30E-03   GSE1009          *Homo sapiens*        Diabetic nephropathy                                                                       Renal tissue
  76     3.57                               1.20E-03   5.87E-03   GSE977           *Mus musculus*        Alexander disease                                                                          CNS, brain, olfactory bulb (MMHCC)
  77     3.55                               5.37E-04   3.35E-03   GSE2826          *Mus musculus*        Bruton\'s agammaglobulinemia                                                               B-cell lymphocyte
  78     3.54                               7.46E-04   4.17E-03   GSE2640          *Mus musculus*        Pulmonary fibrosis                                                                         Lung tissue
  79     3.53                               5.37E-04   3.35E-03   GSE2514          *Homo sapiens*        Adenocarcinoma of lung                                                                     Lung tissue
  80     3.53                               8.90E-04   4.73E-03   GSE1551          *Homo sapiens*        Dermatomyositis                                                                            Muscle, striated (skeletal) (MMHCC)
  81     3.52                               4.50E-04   3.07E-03   GSE2507          *Mus musculus*        Muscular dystrophy                                                                         Muscle, striated (skeletal) (MMHCC)
  82     3.5                                7.15E-04   4.10E-03   GSE3189          *Homo sapiens*        Malignant melanoma                                                                         Epidermis
  83     3.5                                1.10E-03   5.58E-03   GSE4764          *Mus musculus*        *Y. enterocolitica* food poisoning                                                         Lymph node
  84     3.45                               8.68E-04   4.67E-03   EXPE-MEXP-567    *Homo sapiens*        Glioblastoma                                                                               Brain
  85     3.43                               4.44E-04   3.07E-03   GSE3408          *Homo sapiens*        Atypical mycobacterial infection                                                           macrophage
  86     3.43                               1.10E-03   5.58E-03   GSE6428          *Rattus norvegicus*   Type 2 diabetes mellitus                                                                   Endocrine pancreas, islet cell of Langerhans, β-cell (MMHCC)
  87     3.42                               8.45E-04   4.61E-03   GSE10575         *Homo sapiens*        Arthropathy                                                                                Chondrocyte
  88     3.4                                6.73E-04   3.91E-03   GSE9375          *Mus musculus*        Huntington\'s disease                                                                      CNS, brain, striatum (MMHCC)
  89     3.39                               2.10E-03   9.16E-03   GSE4390          *Mus musculus*        ALS                                                                                        CNS, spinal cord (MMHCC)
  90     3.38                               1.21E-03   5.87E-03   GSE3644          *Mus musculus*        Acute pancreatitis                                                                         Pancreas
  91     3.38                               1.30E-03   6.16E-03   GSE3112          *Homo sapiens*        Inclusion body myositides                                                                  Muscle tissue
  92     3.33                               1.10E-03   5.58E-03   GSE466           *Mus musculus*        DMD                                                                                        Muscle, striated (skeletal) (MMHCC)
  93     3.29                               1.40E-03   6.36E-03   GSE2144          *Homo sapiens*        GERD                                                                                       Esophageal tissue
  94     3.27                               1.40E-03   6.36E-03   EXPE-MEXP-1296   *Mus musculus*        Cancer of prostate                                                                         Prostate
  95     3.24                               1.70E-03   7.64E-03   GSE2724          *Homo sapiens*        Uterine leiomyoma                                                                          Uterus
  96     3.21                               3.30E-03   1.30E-02   GSE2825          *Rattus norvegicus*   Idiosyncratic drug effect                                                                  Hepatic tissue
  97     3.19                               2.60E-03   1.08E-02   GSE1007          *Homo sapiens*        DMD                                                                                        Muscle, striated (skeletal) (MMHCC)
  98     3.19                               1.20E-03   5.87E-03   GSE1781          *Rattus norvegicus*   Sepsis                                                                                     Hepatic tissue
  99     3.18                               2.40E-03   1.03E-02   GSE2899          *Mus musculus*        Type 2 diabetes mellitus                                                                   Adipose tissue
  100    3.18                               1.90E-03   8.37E-03   GSE2557          *Mus musculus*        Kidney disorder associated with type 2 diabetes mellitus                                   Mesangial cell
  101    3.18                               1.40E-03   6.36E-03   GSE3524          *Homo sapiens*        Squamous cell carcinoma of mouth                                                           Oropharynx epithelium
  102    3.17                               1.40E-03   6.36E-03   GSE13355         *Homo sapiens*        Psoriasis vulgaris                                                                         Skin tissue
  103    3.15                               2.20E-03   9.50E-03   GSE2866          *Mus musculus*        γ-Hydroxybutyric acidemia                                                                  Cerebral cortex
  104    3.12                               2.60E-03   1.08E-02   GSE4911          *Mus musculus*        Cleidocranial dysostosis                                                                   Humerus
  105    3.12                               1.90E-03   8.37E-03   GSE24807         *Homo sapiens*        NASH                                                                                       Liver
  106    3.12                               3.20E-03   1.28E-02   GSE10631         *Homo sapiens*        LGLL                                                                                       Peripheral blood mononuclear cell
  107    3.11                               2.70E-03   1.11E-02   GSE2052          *Homo sapiens*        Scleroderma                                                                                Lung tissue
  108    3.07                               2.90E-03   1.17E-02   GSE4692          *Mus musculus*        Obesity                                                                                    Adipose tissue
  109    3.05                               2.50E-03   1.06E-02   GSE4824          *Homo sapiens*        Non-small cell lung cancer                                                                 Bronchial epithelium
  110    3.03                               3.80E-03   1.47E-02   GSE1145          *Homo sapiens*        Ischemic cardiomyopathy                                                                    Myocardial tissue
  111    3.01                               4.90E-03   1.77E-02   GSE6678          *Mus musculus*        Infantile neuronal ceroid lipofuscinosis                                                   Brain
  112    3                                  3.30E-03   1.30E-02   GSE3064          *Homo sapiens*        Dystonia                                                                                   Brain
  113    2.99                               4.70E-03   1.72E-02   GSE2527          *Mus musculus*        Thrombocytopenia                                                                           Megakaryocyte
  114    2.99                               4.30E-03   1.62E-02   GSE2433          *Mus musculus*        Leukemia, acute megakaryocytic                                                             Megakaryocyte
  115    2.93                               4.60E-03   1.71E-02   GSE1776          *Mus musculus*        Nutritional deficiency, NEC                                                                Skeletal myocyte
  116    2.93                               3.90E-03   1.49E-02   GSE4587          *Homo sapiens*        In situ melanoma of skin                                                                   Epidermis
  117    2.92                               5.30E-03   1.88E-02   GSE9579          *Homo sapiens*        Appendicitis                                                                               Appendix
  118    2.91                               5.80E-03   2.01E-02   GSE2411          *Mus musculus*        Ventilator-associated lung injury                                                          Lung tissue
  119    2.9                                2.80E-03   1.14E-02   GSE1037          *Homo sapiens*        Small cell carcinoma of lung                                                               Lung tissue
  120    2.86                               5.20E-03   1.86E-02   GSE2401          *Rattus norvegicus*   Hypotensive episode                                                                        Renal tissue
  121    2.85                               4.70E-03   1.72E-02   GSE765           *Mus musculus*        Cystic fibrosis                                                                            Intestinal epithelium
  122    2.83                               3.60E-03   1.40E-02   EXPE-MEXP-882    *Homo sapiens*        Invasive ductal breast cancer                                                              Mammary epithelium
  123    2.83                               6.70E-03   2.28E-02   GSE1869          *Homo sapiens*        Ischemic cardiomyopathy                                                                    Myocardial tissue
  124    2.82                               5.60E-03   1.95E-02   GSE4183          *Homo sapiens*        Adenoma                                                                                    Colon
  125    2.82                               5.40E-03   1.90E-02   GSE1004          *Homo sapiens*        DMD                                                                                        Muscle, striated (skeletal) (MMHCC)
  126    2.81                               4.30E-03   1.62E-02   GSE9944          *Homo sapiens*        Glaucoma                                                                                   Astrocyte
  127    2.79                               6.20E-03   2.13E-02   EXPE-TABM-176    *Homo sapiens*        Irritable bowel syndrome variant of childhood with diarrhea                                Sigmoid colon
  128    2.72                               8.40E-03   2.75E-02   GSE2779          *Homo sapiens*        MDS                                                                                        Bone marrow stem cell
  129    2.72                               7.20E-03   2.43E-02   GSE1947          *Mus musculus*        Peripheral motor neuropathy                                                                Sciatic nerve
  130    2.71                               8.40E-03   2.75E-02   GSE593           *Homo sapiens*        Uterine leiomyoma                                                                          Uterus, myometrium (MMHCC)
  131    2.71                               7.50E-03   2.52E-02   GSE2712          *Homo sapiens*        Clear cell sarcoma of kidney                                                               Renal tissue
  132    2.69                               8.50E-03   2.75E-02   GSE1459          *Mus musculus*        Bacterial Infection                                                                        Macrophage
  133    2.67                               8.50E-03   2.75E-02   GSE1811          *Mus musculus*        Occupational lung disease                                                                  Lung Tissue
  134    2.67                               8.90E-03   2.85E-02   GSE2508          *Homo sapiens*        Obesity                                                                                    Adipocyte
  135    2.66                               8.10E-03   2.70E-02   GSE1462          *Homo sapiens*        MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes)   Muscle, striated (skeletal) (MMHCC)
  136    2.65                               9.00E-03   2.86E-02   GSE4130          *Rattus norvegicus*   Dehydration                                                                                CNS, brain, hypothalamus (MMHCC)
  137    2.61                               9.10E-03   2.88E-02   GSE1378          *Homo sapiens*        Breast cancer                                                                              Mammary gland tissue
  138    2.6                                1.14E-02   3.45E-02   GSE1375          *Mus musculus*        Alzheimer\'s disease                                                                       Cerebral cortex
  139    2.59                               9.80E-03   3.03E-02   GSE2719          *Homo sapiens*        Gastrointestinal stromal tumor                                                             Connective tissue
  140    2.59                               9.60E-03   3.01E-02   GSE7036          *Homo sapiens*        Bipolar disorder                                                                           Lymphocyte
  141    2.57                               1.00E-02   3.07E-02   GSE1724          *Homo sapiens*        Scleroderma                                                                                Fibroblast
  142    2.56                               9.70E-03   3.02E-02   GSE3790          *Homo sapiens*        Huntington\'s disease                                                                      Caudate nucleus
  143    2.55                               1.25E-02   3.68E-02   GSE6764          *Homo sapiens*        Hepatic cirrhosis                                                                          Liver
  144    2.54                               1.24E-02   3.68E-02   GSE2457          *Rattus norvegicus*   Erectile dysfunction associated with type 2 diabetes mellitus                              Penis, NOS
  145    2.54                               1.47E-02   4.14E-02   GSE2457          *Rattus norvegicus*   Erectile dysfunction                                                                       Penis erectile tissue
  146    2.54                               1.05E-02   3.20E-02   GSE3110          *Rattus norvegicus*   Dehydration                                                                                Hypothalamus
  147    2.53                               1.22E-02   3.64E-02   GSE2712          *Homo sapiens*        Nephroblastoma                                                                             Renal tissue
  148    2.51                               1.42E-02   4.05E-02   GSE7999          *Rattus norvegicus*   Tachycardia                                                                                Myocardial tissue
  149    2.51                               1.29E-02   3.77E-02   GSE609           *Homo sapiens*        SCID                                                                                       Thymic lymphocyte
  150    2.49                               1.19E-02   3.58E-02   GSE1869          *Homo sapiens*        Cardiomyopathy                                                                             Myocardial tissue
  151    2.49                               1.36E-02   3.93E-02   GSE7621          *Homo sapiens*        Parkinson\'s disease                                                                       Substantia nigra
  152    2.48                               1.35E-02   3.92E-02   GSE10971         *Homo sapiens*        Serous carcinoma                                                                           Fallopian tube
  153    2.48                               1.40E-02   4.02E-02   GSE3418          *Mus musculus*        Lung transplant rejection                                                                  Trachea
  154    2.47                               1.45E-02   4.11E-02   EXPE-MEXP-476    *Homo sapiens*        Cancer of prostate                                                                         Endothelial cell
  155    2.47                               1.54E-02   4.28E-02   GSE3184          *Mus musculus*        Asthma, allergic                                                                           Lung tissue
  156    2.46                               1.49E-02   4.16E-02   GSE4616          *Mus musculus*        Type 1 diabetes mellitus                                                                   Myocardial tissue
  157    2.41                               1.68E-02   4.64E-02   GSE4612          *Mus musculus*        Carcinoma, hepatocellular                                                                  Hepatic tissue
  158    2.4                                1.77E-02   4.85E-02   GSE2725          *Homo sapiens*        Uterine leiomyoma                                                                          Uterus
  159    2.39                               1.81E-02   4.90E-02   GSE3365          *Homo sapiens*        Ulcerative colitis                                                                         Peripheral blood mononuclear cell
  160    2.37                               1.80E-02   4.90E-02   GSE1813          *Rattus norvegicus*   Obesity                                                                                    Adipose tissue
  161    2.36                               1.87E-02   5.03E-02   GSE4060          *Homo sapiens*        Cushing syndrome                                                                           Adrenal gland
  162    2.35                               2.07E-02   5.50E-02   GSE1145          *Homo sapiens*        Primary cardiomyopathy                                                                     Myocardial tissue
  163    2.31                               1.88E-02   5.03E-02   GSE6461          *Mus musculus*        Synovial sarcoma                                                                           Synovial membrane
  164    2.3                                2.15E-02   5.68E-02   GSE1037          *Homo sapiens*        Non-small cell lung cancer                                                                 Lung tissue
  165    2.27                               2.29E-02   6.01E-02   GSE10921         *Homo sapiens*        Idiopathic fibrosing alveolitis                                                            Fibroblast
  166    2.26                               2.41E-02   6.28E-02   GSE3248          *Mus musculus*        Huntington\'s disease                                                                      CNS, brain, cerebellum (MMHCC)
  167    2.25                               2.42E-02   6.28E-02   GSE4788          *Mus musculus*        Parkinson\'s disease                                                                       Substantia nigra
  168    2.24                               2.52E-02   6.46E-02   GSE4710          *Mus musculus*        Heart injury                                                                               Myocardial tissue
  169    2.21                               2.52E-02   6.46E-02   GSE6364          *Homo sapiens*        Endometriosis                                                                              Endometrium
  170    2.2                                2.68E-02   6.83E-02   GSE1462          *Homo sapiens*        CPEO (chronic progressive external ophthalmoplegia)                                        Muscle, striated (skeletal) (MMHCC)
  171    2.19                               3.00E-02   7.56E-02   GSE1724          *Homo sapiens*        Idiopathic fibrosing alveolitis                                                            Fibroblast
  172    2.18                               2.87E-02   7.28E-02   GSE6955          *Homo sapiens*        Rett syndrome                                                                              frontal cortex
  173    2.13                               3.24E-02   8.12E-02   GSE1017          *Homo sapiens*        Myopathy NOS                                                                               Skeletal muscle
  174    2.13                               3.39E-02   8.45E-02   GSE2429          *Homo sapiens*        Breast cancer                                                                              Mammary gland tissue
  175    2.12                               3.57E-02   8.79E-02   GSE6764          *Homo sapiens*        Hepatocellular dysplasia                                                                   Liver
  176    2.11                               3.64E-02   8.92E-02   GSE4516          *Rattus norvegicus*   Smoke inhalation                                                                           Lung tissue
  177    2.1                                3.41E-02   8.45E-02   GSE567           *Homo sapiens*        Essential thrombocythemia                                                                  Megakaryocyte
  178    2.09                               3.92E-02   9.39E-02   EXPE-TABM-176    *Homo sapiens*        Irritable bowel syndrome variant of childhood with constipation                            Sigmoid colon
  179    2.08                               3.69E-02   8.99E-02   GSE4130          *Rattus norvegicus*   Dehydration                                                                                Pituitary gland
  180    2.07                               3.72E-02   9.01E-02   GSE9006          *Homo sapiens*        Type 2 diabetes mellitus                                                                   Peripheral blood mononuclear cell
  181    2.06                               4.00E-02   9.40E-02   GSE2899          *Mus musculus*        Type 2 diabetes mellitus                                                                   Soleus muscle
  182    2.06                               4.01E-02   9.40E-02   GSE3125          *Rattus norvegicus*   Dehydration                                                                                Hypothalamus
  183    2.06                               3.99E-02   9.40E-02   GSE3407          *Homo sapiens*        Cockayne syndrome                                                                          Fibroblast
  184    2.06                               3.79E-02   9.13E-02   GSE2866          *Mus musculus*        γ-Hydroxybutyric acidemia                                                                  Hippocampus
  185    2.05                               4.07E-02   9.49E-02   GSE2077          *Homo sapiens*        Protozoan Infection                                                                        Intestinal epithelium
  186    2.05                               4.14E-02   9.60E-02   GSE9006          *Homo sapiens*        Type 1 diabetes mellitus                                                                   Peripheral blood mononuclear cell
  187    2.03                               4.01E-02   9.40E-02   GSE10123         *Homo sapiens*        Premature aging                                                                            Skin fibroblast
  188    2.01                               4.45E-02   1.01E-01   GSE3365          *Homo sapiens*        Crohn\'s disease                                                                           Peripheral blood mononuclear cell
  189    2.01                               4.33E-02   9.99E-02   GSE1297          *Homo sapiens*        Alzheimer\'s disease                                                                       Hippocampus
  190    2                                  4.40E-02   1.01E-01   GSE2254          *Mus musculus*        Type 1 diabetes mellitus                                                                   pancreatic islet
  191    2                                  4.57E-02   1.03E-01   GSE3489          *Homo sapiens*        HIV encephalitis                                                                           frontal cortex
  192    2                                  4.44E-02   1.01E-01   GSE3203          *Mus musculus*        Influenza                                                                                  B-cell lymphocyte
  193    1.99                               4.67E-02   1.05E-01   GSE2559          *Homo sapiens*        Pulmonary hypertension, primary                                                            Pulmonary artery
  194    1.98                               4.76E-02   1.06E-01   GSE3807          *Homo sapiens*        Aplastic anemia                                                                            Bone marrow
  195    1.98                               4.85E-02   1.07E-01   GSE4105          *Rattus norvegicus*   Myocardial infarction                                                                      Myocardial tissue
  196    1.96                               4.72E-02   1.06E-01   GSE4479          *Mus musculus*        Sepsis                                                                                     Splenocyte
  197    1.95                               5.26E-02   1.15E-01   GSE3676          *Mus musculus*        Infertility due to azoospermia                                                             Testicular tissue
  198    1.94                               5.21E-02   1.15E-01   GSE10064         *Homo sapiens*        MS                                                                                         B-cell lymphocyte
  199    1.93                               5.48E-02   1.17E-01   GSE5090          *Homo sapiens*        Polycystic ovary syndrome                                                                  Adipose tissue
  200    1.93                               5.43E-02   1.17E-01   GSE11            *Mus musculus*        Type 1 diabetes mellitus                                                                   Thymic epithelial cell
  201    1.92                               5.28E-02   1.15E-01   GSE582           *Mus musculus*        Transplanted heart complication                                                            Myocardial tissue
  202    1.92                               5.44E-02   1.17E-01   GSE10586         *Homo sapiens*        Type 1 diabetes mellitus                                                                   T lymphocyte
  203    1.92                               5.77E-02   1.21E-01   GSE2049          *Homo sapiens*        AML                                                                                        Haematopoietic stem cell
  204    1.91                               5.56E-02   1.18E-01   GSE11208         *Homo sapiens*        Nicotine addiction                                                                         Ganglioneuroblastoma
  205    1.91                               5.61E-02   1.18E-01   GSE5538          *Mus musculus*        Hepatic lipidosis                                                                          Hepatic Tissue
  206    1.9                                5.37E-02   1.16E-01   EXPE-MEXP-692    *Homo sapiens*        Barrett esophagus                                                                          Esophagus
  207    1.9                                5.60E-02   1.18E-01   GSE1659          *Mus musculus*        Type 1 diabetes mellitus                                                                   Muscle, striated (skeletal) (MMHCC)
  208    1.89                               6.00E-02   1.25E-01   GSE4170          *Homo sapiens*        CML                                                                                        Haematopoietic stem cell
  209    1.88                               6.33E-02   1.31E-01   EXPE-MEXP-692    *Homo sapiens*        Adenocarcinoma of esophagus                                                                Esophagus
  210    1.86                               6.21E-02   1.29E-01   GSE422           *Mus musculus*        Carcinoma *in situ* of small intestine                                                     Intestinal epithelium
  211    1.82                               6.93E-02   1.41E-01   GSE1822          *Homo sapiens*        Ewing\'s sarcoma                                                                           Renal tissue
  212    1.81                               6.69E-02   1.37E-01   GSE755           *Homo sapiens*        Osteolysis                                                                                 Leukocyte, lymphocyte, B lymphocyte, plasma cell (MMHCC)
  213    1.81                               6.60E-02   1.36E-01   GSE3004          *Homo sapiens*        Asthma, allergic                                                                           Bronchial epithelium
  214    1.78                               7.26E-02   1.47E-01   GSE4060          *Homo sapiens*        ACTH-dependent Cushing syndrome                                                            Adrenal gland
  215    1.76                               7.71E-02   1.54E-01   GSE4120          *Mus musculus*        Arrhythmogenic right ventricular cardiomyopathy                                            Myocardial tissue
  216    1.76                               8.01E-02   1.59E-01   GSE3790          *Homo sapiens*        Huntington\'s disease                                                                      frontal cortex
  217    1.76                               7.70E-02   1.54E-01   GSE9800          *Homo sapiens*        Cardiomyopathy, dilated                                                                    Myocardial tissue
  218    1.71                               8.68E-02   1.70E-01   GSE3915          *Mus musculus*        Cancer of the intestine                                                                    Small bowel
  219    1.69                               9.30E-02   1.80E-01   GSE5581          *Mus musculus*        Retinoschisis                                                                              Retina
  220    1.68                               8.96E-02   1.75E-01   GSE868           *Mus musculus*        Familial hypophosphatemic rickets                                                          Renal tissue
  221    1.68                               8.99E-02   1.75E-01   EXPE-TABM-176    *Homo sapiens*        IBS                                                                                        Sigmoid colon
  222    1.66                               9.61E-02   1.85E-01   GSE6965          *Homo sapiens*        Infection by *Aspergillus fumigatus*                                                       Dendritic cell
  223    1.66                               9.71E-02   1.87E-01   GSE6012          *Homo sapiens*        Eczema                                                                                     Integument
  224    1.65                               9.80E-02   1.87E-01   GSE3554          *Mus musculus*        Glaucoma                                                                                   Retina
  225    1.65                               1.00E-01   1.90E-01   GSE2223          *Homo sapiens*        Glioblastoma                                                                               CNS, brain (MMHCC)
  226    1.63                               9.98E-02   1.90E-01   EXPE-TABM-26     *Homo sapiens*        Cancer of prostate                                                                         Prostate
  227    1.62                               1.03E-01   1.94E-01   GSE4172          *Homo sapiens*        Viral cardiomyopathy                                                                       Myocardial tissue
  228    1.6                                1.08E-01   2.01E-01   GSE2191          *Homo sapiens*        AML                                                                                        Mononuclear leukocyte
  229    1.6                                1.08E-01   2.01E-01   GSE2155          *Homo sapiens*        Breast cancer                                                                              Epithelial cell
  230    1.56                               1.18E-01   2.16E-01   GSE1299          *Homo sapiens*        Breast cancer                                                                              Mammary epithelium
  231    1.55                               1.15E-01   2.13E-01   GSE3320          *Homo sapiens*        COPD                                                                                       Bronchial epithelium
  232    1.55                               1.19E-01   2.17E-01   GSE5774          *Homo sapiens*        Nonspecific interstitial pneumonia                                                         Lung tissue
  233    1.55                               1.18E-01   2.16E-01   GSE6710          *Homo sapiens*        Psoriasis vulgaris                                                                         Skin tissue
  234    1.53                               1.29E-01   2.31E-01   GSE4250          *Homo sapiens*        Hereditary gingival fibromatosis                                                           Gingiva
  235    1.53                               1.24E-01   2.25E-01   GSE5364          *Homo sapiens*        Cancer of thyroid                                                                          Thyroid
  236    1.53                               1.18E-01   2.16E-01   GSE3583          *Mus musculus*        Huntington\'s disease                                                                      CNS, brain, striatum (MMHCC)
  237    1.52                               1.30E-01   2.32E-01   GSE12654         *Homo sapiens*        Bipolar disorder                                                                           Cerebral cortex
  238    1.52                               1.29E-01   2.31E-01   GSE973           *Homo sapiens*        Funisitis                                                                                  Umbilical blood
  239    1.51                               1.32E-01   2.34E-01   GSE12649         *Homo sapiens*        Bipolar disorder                                                                           Cerebral cortex
  240    1.5                                1.33E-01   2.35E-01   GSE925           *Rattus norvegicus*   Cardiac hypertrophy                                                                        Cardiomyocyte
  241    1.48                               1.38E-01   2.42E-01   GSE3544          *Mus musculus*        MODY                                                                                       Pancreatic islet
  242    1.47                               1.42E-01   2.46E-01   GSE420           *Homo sapiens*        Atherosclerosis                                                                            Aorta smooth muscle tissue
  243    1.47                               1.37E-01   2.42E-01   GSE422           *Mus musculus*        Adenoma of small intestine                                                                 Intestinal epithelium
  244    1.46                               1.41E-01   2.46E-01   EXPE-TABM-36     *Homo sapiens*        Hepatocellular adenoma                                                                     Hepatocyte
  245    1.45                               1.38E-01   2.42E-01   GSE4302          *Homo sapiens*        Asthma                                                                                     Epithelial cell
  246    1.45                               1.44E-01   2.50E-01   GSE5370          *Homo sapiens*        Dermatomyositis                                                                            Muscle, striated (skeletal) (MMHCC)
  247    1.42                               1.53E-01   2.61E-01   GSE2172          *Mus musculus*        Colitis                                                                                    Intestine, large intestine, colon (MMHCC)
  248    1.41                               1.55E-01   2.63E-01   GSE11750         *Homo sapiens*        Senescence                                                                                 Muscle, striated (skeletal) (MMHCC)
  249    1.41                               1.56E-01   2.63E-01   GSE3             *Homo sapiens*        Chromophobe cell carcinoma of kidney                                                       Renal cell
  250    1.41                               1.52E-01   2.61E-01   GSE2705          *Homo sapiens*        Primary open angle glaucoma                                                                Optic disk
  251    1.37                               1.68E-01   2.80E-01   GSE3860          *Homo sapiens*        Progeria                                                                                   Fibroblast
  252    1.37                               1.73E-01   2.86E-01   GSE674           *Homo sapiens*        Senescence                                                                                 Muscle, striated (skeletal) (MMHCC)
  253    1.36                               1.72E-01   2.84E-01   GSE2549          *Homo sapiens*        Malignant mesothelioma of pleura                                                           Pleura
  254    1.36                               1.71E-01   2.84E-01   GSE1466          *Homo sapiens*        Lymphoblastic leukemia                                                                     T lymphocyte
  255    1.33                               1.82E-01   2.97E-01   GSE1611          *Mus musculus*        Down syndrome                                                                              CNS, brain, cerebellum (MMHCC)
  256    1.33                               1.79E-01   2.93E-01   GSE997           *Homo sapiens*        Essential thrombocythemia                                                                  Megakaryocyte
  257    1.32                               1.91E-01   3.09E-01   GSE6798          *Homo sapiens*        Polycystic ovary syndrome                                                                  Skeletal muscle
  258    1.32                               1.83E-01   2.98E-01   GSE3790          *Homo sapiens*        Huntington\'s disease                                                                      CNS, brain, cerebellum (MMHCC)
  259    1.31                               1.87E-01   3.03E-01   GSE2503          *Homo sapiens*        Actinic keratosis                                                                          Skin tissue
  260    1.29                               1.94E-01   3.12E-01   GSE1010          *Homo sapiens*        Familial combined hyperlipidemia                                                           Lymphoblast
  261    1.27                               2.00E-01   3.17E-01   GSE1028          *Homo sapiens*        Scott syndrome                                                                             B-cell lymphocyte
  262    1.27                               1.98E-01   3.16E-01   GSE5388          *Homo sapiens*        Bipolar disorder                                                                           Frontal cortex
  263    1.27                               2.00E-01   3.17E-01   GSE2067          *Homo sapiens*        Hepatitis C infection                                                                      Hepatocyte
  264    1.26                               2.04E-01   3.22E-01   GSE3280          *Homo sapiens*        Acute monocytic leukemia                                                                   Blood monocyte
  265    1.26                               2.07E-01   3.24E-01   GSE642           *Mus musculus*        Type 2 diabetes mellitus                                                                   Renal tissue
  266    1.26                               2.07E-01   3.24E-01   GSE5281          *Homo sapiens*        Alzheimer\'s disease                                                                       Superior frontal gyrus
  267    1.21                               2.28E-01   3.54E-01   GSE11348         *Homo sapiens*        Rhinovirus infection                                                                       Nose
  268    1.2                                2.34E-01   3.61E-01   GSE7486          *Homo sapiens*        Epilepsy                                                                                   Lymphoblast
  269    1.16                               2.46E-01   3.74E-01   GSE3384          *Mus musculus*        Nemaline myopathy                                                                          Tibialis Muscle
  270    1.16                               2.45E-01   3.73E-01   GSE473           *Homo sapiens*        Asthma                                                                                     CD4-positive lymphocyte
  271    1.16                               2.45E-01   3.73E-01   GSE474           *Homo sapiens*        Obesity                                                                                    Muscle, striated (skeletal) (MMHCC)
  272    1.14                               2.50E-01   3.78E-01   EXPE-MEXP-669    *NULL*                Neuroblastoma                                                                              Adrenal cortex
  273    1.12                               2.62E-01   3.95E-01   GSE3889          *Mus musculus*        Hypercholesterolemia                                                                       Hepatic tissue
  274    1.11                               2.66E-01   3.97E-01   GSE2175          *Homo sapiens*        Adenoma of pituitary gland                                                                 Pituitary gland
  275    1.1                                2.71E-01   4.03E-01   GSE3925          *Mus musculus*        Hyperreactive airway disease                                                               Lung tissue
  276    1.09                               2.79E-01   4.13E-01   GSE10162         *Mus musculus*        Nephrolithiasis                                                                            Kidney
  277    1.09                               2.62E-01   3.95E-01   GSE2470          *Rattus norvegicus*   Type 2 diabetes mellitus                                                                   Pancreas
  278    1.08                               2.77E-01   4.10E-01   GSE362           *Homo sapiens*        Senescence                                                                                 Muscle, striated (skeletal) (MMHCC)
  279    1.06                               2.87E-01   4.23E-01   GSE2973          *Mus musculus*        Infection by *Y. enterocolitica*                                                           Macrophage
  280    1.04                               2.98E-01   4.35E-01   GSE4785          *Homo sapiens*        Simian acquired immune deficiency syndrome                                                 T lymphocyte
  281    1.04                               2.97E-01   4.35E-01   GSE923           *Homo sapiens*        *Pseudomonas* infection                                                                    Lung tissue
  282    1.02                               3.07E-01   4.46E-01   GSE12654         *Homo sapiens*        Depression                                                                                 Cerebral cortex
  283    1.01                               3.08E-01   4.47E-01   GSE2053          *Homo sapiens*        RA                                                                                         Synovial membrane
  284    1.01                               3.14E-01   4.54E-01   GSE1037          *Homo sapiens*        Adenocarcinoma of lung                                                                     Lung tissue
  285    1                                  3.18E-01   4.58E-01   GSE4333          *Mus musculus*        Lymphatic edema                                                                            Skin tissue
  286    0.99                               3.22E-01   4.62E-01   GSE10964         *Mus musculus*        COPD                                                                                       Lung
  287    0.99                               3.28E-01   4.69E-01   GSE2657          *Homo sapiens*        Sarcoidosis                                                                                T lymphocyte
  288    0.96                               3.41E-01   4.81E-01   GSE1767          *Homo sapiens*        Huntington\'s disease                                                                      Blood
  289    0.96                               3.35E-01   4.77E-01   GSE7753          *Homo sapiens*        JRA                                                                                        Peripheral blood mononuclear cell
  290    0.95                               3.40E-01   4.81E-01   GSE4125          *Homo sapiens*        Adenocarcinoma of kidney                                                                   Kidney
  291    0.94                               3.46E-01   4.87E-01   GSE8762          *Homo sapiens*        Huntington\'s disease                                                                      Lymphocyte
  292    0.93                               3.48E-01   4.88E-01   GSE5788          *Homo sapiens*        Leukemia, chronic T cell                                                                   T lymphocyte
  293    0.92                               3.56E-01   4.98E-01   GSE483           *Mus musculus*        Asthma, allergic                                                                           Lung tissue
  294    0.91                               3.58E-01   4.99E-01   GSE2566          *Rattus norvegicus*   Neurogenic muscular atrophy                                                                Muscle, striated (skeletal) (MMHCC)
  295    0.91                               3.60E-01   4.99E-01   GSE2600          *Homo sapiens*        Anaplasmosis                                                                               Leukemic cell
  296    0.91                               3.68E-01   5.06E-01   GSE2127          *Mus musculus*        Carcinoma, hepatocellular                                                                  Hepatic tissue
  297    0.91                               3.59E-01   4.99E-01   GSE2052          *Homo sapiens*        MCTD                                                                                       Lung tissue
  298    0.84                               3.85E-01   5.26E-01   GSE2276          *Mus musculus*        Asthma, allergic                                                                           Lung tissue
  299    0.84                               4.07E-01   5.52E-01   GSE4707          *Homo sapiens*        Preeclampsia                                                                               Placenta
  300    0.81                               4.22E-01   5.68E-01   GSE3871          *Homo sapiens*        Androgen insensitivity syndrome                                                            Fibroblast
  301    0.81                               4.17E-01   5.63E-01   GSE1606          *Mus musculus*        Turner syndrome                                                                            CNS, brain (MMHCC)
  302    0.8                                4.27E-01   5.70E-01   GSE1674          *Mus musculus*        Hypertension                                                                               Adrenal gland
  303    0.8                                4.28E-01   5.70E-01   GSE3195          *Mus musculus*        Hypoxia                                                                                    Fibroblast
  304    0.79                               4.28E-01   5.70E-01   GSE475           *Homo sapiens*        COPD                                                                                       Muscle, striated (skeletal), diaphragm (MMHCC)
  305    0.79                               4.34E-01   5.75E-01   GSE1872          *Rattus norvegicus*   Breast cancer                                                                              Mammary gland tissue
  306    0.79                               4.29E-01   5.70E-01   GSE3868          *Homo sapiens*        Cancer of prostate                                                                         Prostate
  307    0.76                               4.46E-01   5.87E-01   EXPE-MEXP-669    *NULL*                Neuroblastoma                                                                              Adrenal cortex
  308    0.76                               4.43E-01   5.85E-01   GSE5109          *Homo sapiens*        Obesity                                                                                    Muscle, striated (skeletal) (MMHCC)
  309    0.73                               4.64E-01   6.07E-01   GSE1413          *Mus musculus*        Cancer of prostate                                                                         Prostate
  310    0.72                               4.76E-01   6.18E-01   GSE5281          *Homo sapiens*        Alzheimer\'s Disease                                                                       Middle temporal gyrus
  311    0.72                               4.71E-01   6.15E-01   GSE3384          *Mus musculus*        Nemaline myopathy                                                                          Extensor digitorum longus muscle
  312    0.69                               4.89E-01   6.32E-01   GSE2223          *Homo sapiens*        Astrocytoma                                                                                CNS, brain (MMHCC)
  313    0.68                               4.97E-01   6.42E-01   EXPE-MEXP-476    *Homo sapiens*        Cancer of prostate                                                                         Endothelial cell
  314    0.68                               4.99E-01   6.42E-01   EXPE-MEXP-476    *Homo sapiens*        Cancer of prostate                                                                         Endothelial cell
  315    0.66                               5.10E-01   6.54E-01   GSE9877          *Homo sapiens*        Sickle cell anemia                                                                         Endothelial cell
  316    0.65                               5.18E-01   6.62E-01   GSE3026          *Homo sapiens*        Bacterial infection                                                                        Peripheral blood mononuclear cell
  317    0.63                               5.30E-01   6.76E-01   GSE128           *Mus musculus*        Retinitis pigmentosa                                                                       Retina
  318    0.61                               5.34E-01   6.77E-01   GSE1379          *Homo sapiens*        Breast cancer                                                                              Mammary gland tissue
  319    0.58                               5.63E-01   7.02E-01   GSE867           *Mus musculus*        Hepatitis, autoimmune                                                                      Hepatic tissue
  320    0.58                               5.63E-01   7.02E-01   GSE465           *Homo sapiens*        DMD                                                                                        Muscle, striated (skeletal) (MMHCC)
  321    0.58                               5.61E-01   7.02E-01   GSE1871          *Mus musculus*        Acute lung injury                                                                          Lung tissue
  322    0.57                               5.65E-01   7.02E-01   GSE5900          *Homo sapiens*        MGUS                                                                                       Bone marrow
  323    0.57                               5.70E-01   7.02E-01   GSE2223          *Homo sapiens*        Oligodendroglioma                                                                          CNS, brain (MMHCC)
  324    0.57                               5.65E-01   7.02E-01   GSE1055          *Rattus norvegicus*   Cardiac hypertrophy                                                                        Cardiomyocyte
  325    0.57                               5.70E-01   7.02E-01   GSE4748          *Homo sapiens*        Bacterial infection                                                                        Dendritic cell
  326    0.57                               5.73E-01   7.03E-01   GSE3384          *Mus musculus*        Nemaline myopathy                                                                          Muscle, striated (skeletal), diaphragm (MMHCC)
  327    0.57                               5.70E-01   7.02E-01   GSE2236          *Mus musculus*        Congestive heart disease                                                                   Myocardial tissue
  328    0.56                               5.74E-01   7.03E-01   GSE1008          *Mus musculus*        DMD                                                                                        Extraocular muscle
  329    0.53                               5.90E-01   7.15E-01   GSE1472          *Mus musculus*        DMD                                                                                        Extraocular muscle
  330    0.53                               6.02E-01   7.20E-01   GSE85            *Mus musculus*        APECED                                                                                     Thymic epithelial cell
  331    0.53                               5.92E-01   7.15E-01   GSE1849          *Homo sapiens*        Sickle cell anemia                                                                         Pulmonary artery
  332    0.52                               5.99E-01   7.19E-01   GSE3311          *Rattus norvegicus*   Alcohol poisoning                                                                          Pancreas
  333    0.51                               6.03E-01   7.21E-01   GSE2503          *Homo sapiens*        Squamous cell carcinoma                                                                    Skin tissue
  334    0.5                                6.17E-01   7.35E-01   GSE2899          *Mus musculus*        Type 2 diabetes mellitus                                                                   Hepatic tissue
  335    0.48                               6.26E-01   7.42E-01   GSE1739          *Homo sapiens*        SARS                                                                                       Peripheral blood mononuclear cell
  336    0.46                               6.46E-01   7.57E-01   GSE5900          *Homo sapiens*        Smoldering multiple myeloma                                                                Bone marrow
  337    0.45                               6.64E-01   7.74E-01   GSE4678          *Mus musculus*        Ventricular hypertrophy                                                                    Myocardial tissue
  338    0.43                               6.63E-01   7.74E-01   GSE4128          *Mus musculus*        Adenovirus infection                                                                       Hepatic tissue
  339    0.42                               6.79E-01   7.81E-01   GSE11889         *Homo sapiens*        CML                                                                                        Hematopoietic stem cell
  340    0.42                               6.72E-01   7.79E-01   GSE2779          *Homo sapiens*        Vitamin B 12 deficiency                                                                    Bone marrow stem cell
  341    0.4                                6.89E-01   7.90E-01   GSE3             *Homo sapiens*        Clear cell carcinoma of kidney                                                             Renal cell
  342    0.38                               7.02E-01   7.97E-01   GSE9692          *Homo sapiens*        Septic shock                                                                               Whole blood
  343    0.38                               7.10E-01   8.01E-01   GSE6740          *Homo sapiens*        HIV                                                                                        T lymphocyte
  344    0.36                               7.13E-01   8.03E-01   GSE121           *Homo sapiens*        Type 2 diabetes mellitus                                                                   Muscle tissue
  345    0.36                               7.25E-01   8.14E-01   GSE1402          *Homo sapiens*        Spondyloarthropathy                                                                        Peripheral blood mononuclear cell
  346    0.34                               7.34E-01   8.20E-01   GSE2271          *Mus musculus*        Hypoxia                                                                                    Heart
  347    0.34                               7.40E-01   8.21E-01   GSE2466          *Homo sapiens*        Lymphocytic leukemia, chronic, B Cell                                                      PBL
  348    0.34                               7.37E-01   8.21E-01   GSE1751          *Homo sapiens*        Huntington\'s disease                                                                      Blood
  349    0.28                               7.76E-01   8.48E-01   GSE10211         *Mus musculus*        Sendai virus infection                                                                     Tracheal epithelium
  350    0.27                               7.86E-01   8.57E-01   GSE2379          *Homo sapiens*        Hypopharyngeal cancer                                                                      Pharynx
  351    0.25                               8.01E-01   8.70E-01   GSE2884          *Rattus norvegicus*   Neurological pain disorder                                                                 Dorsal root ganglia
  352    0.24                               8.02E-01   8.70E-01   GSE1560          *Mus musculus*        Atherosclerosis                                                                            Aorta smooth muscle tissue
  353    0.19                               8.51E-01   9.11E-01   GSE18803         *Rattus norvegicus*   Neurological pain disorder                                                                 CNS, spinal cord (MMHCC)
  354    0.17                               8.63E-01   9.18E-01   GSE1124          *Homo sapiens*        Malaria                                                                                    Blood
  355    0.17                               8.69E-01   9.19E-01   EXPE-MEXP-1050   *Homo sapiens*        IUGR                                                                                       Decidua basalis
  356    0.15                               8.82E-01   9.28E-01   GSE4697          *Mus musculus*        Obesity                                                                                    Adipose tissue
  357    0.12                               9.02E-01   9.43E-01   GSE3249          *Mus musculus*        Leber congenital amaurosis                                                                 Retina
  358    0.12                               9.02E-01   9.43E-01   GSE1852          *Mus musculus*        Marfan's syndrome                                                                          Myocardial tissue
  359    0.08                               9.34E-01   9.66E-01   GSE7654          *Rattus norvegicus*   Hepatitis                                                                                  Liver
  360    0.08                               9.35E-01   9.66E-01   GSE2504          *Homo sapiens*        HIV                                                                                        T lymphocyte
  361    0.08                               9.39E-01   9.66E-01   GSE1710          *Homo sapiens*        Ulcerative colitis                                                                         Sigmoid colon
  362    0.08                               9.40E-01   9.66E-01   GSE3167          *Homo sapiens*        Urothelial carcinoma                                                                       Urothelium
  363    0.07                               9.45E-01   9.66E-01   GSE5281          *Homo sapiens*        Alzheimer\'s disease                                                                       Entorhinal cortex
  364    0.07                               9.46E-01   9.66E-01   GSE3586          *Homo sapiens*        Cardiomyopathy, dilated                                                                    Myocardial tissue
  365    0.04                               9.70E-01   9.88E-01   GSE10758         *Homo sapiens*        Down syndrome                                                                              Fetus
  366    0.02                               9.82E-01   9.89E-01   GSE15966         *Homo sapiens*        Gastrointestinal stromal tumor                                                             Gastric tissue
  367    0.01                               9.94E-01   9.96E-01   GSE11969         *Homo sapiens*        Small cell carcinoma of lung                                                               Lung tissue
  368    0                                  9.98E-01   9.98E-01   GSE4482          *Homo sapiens*        Cancer of cervix                                                                           Cervix
  369    −0.01                              9.93E-01   9.96E-01   GSE11393         *Homo sapiens*        Familial combined hyperlipidemia                                                           Blood monocyte
  370    −0.02                              9.81E-01   9.89E-01   GSE10474         *Homo sapiens*        Acute lung injury                                                                          Whole blood
  371    −0.02                              9.81E-01   9.89E-01   GSE574           *Homo sapiens*        Purpura, idiopathic thrombocytopenic                                                       T lymphocyte
  372    −0.02                              9.80E-01   9.89E-01   GSE3827          *Homo sapiens*        CBCL                                                                                       Skin tissue
  373    −0.03                              9.76E-01   9.89E-01   GSE8835          *Homo sapiens*        B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma                             Peripheral blood mononuclear cell
  374    −0.07                              9.42E-01   9.66E-01   GSE2779          *Homo sapiens*        Folic acid deficiency                                                                      Bone marrow stem cell
  375    −0.1                               9.19E-01   9.54E-01   GSE860           *Homo sapiens*        PTSD                                                                                       Peripheral blood mononuclear cell
  376    −0.11                              9.18E-01   9.54E-01   GSE2935          *Mus musculus*        Sendai virus infection                                                                     Macrophage
  377    −0.11                              9.15E-01   9.54E-01   GSE4483          *Homo sapiens*        Hypoxia                                                                                    Astrocyte
  378    −0.14                              8.89E-01   9.34E-01   GSE1650          *Homo sapiens*        COPD                                                                                       Lung tissue
  379    −0.16                              8.74E-01   9.23E-01   EXPE-MEXP-1278   *Rattus norvegicus*   Arteriotomy                                                                                Carotid artery
  380    −0.17                              8.68E-01   9.19E-01   GSE1541          *Homo sapiens*        Lung injury                                                                                Lung tissue
  381    −0.18                              8.52E-01   9.11E-01   GSE2899          *Mus musculus*        Type 2 diabetes mellitus                                                                   pancreatic islet
  382    −0.19                              8.55E-01   9.12E-01   GSE935           *Homo sapiens*        Granulomatous disease, chronic                                                             Blood neutrophil
  383    −0.19                              8.42E-01   9.06E-01   GSE2171          *Homo sapiens*        HIV infection                                                                              Peripheral blood mononuclear cell
  384    −0.2                               8.46E-01   9.08E-01   GSE4036          *Homo sapiens*        Schizophrenia                                                                              CNS, brain, cerebellum (MMHCC)
  385    −0.22                              8.27E-01   8.93E-01   GSE14245         *Homo sapiens*        Malignant tumor of pancreas                                                                Saliva
  386    −0.24                              8.06E-01   8.72E-01   GSE2459          *Mus musculus*        Hypertrophy, left ventricular                                                              Myocardial tissue
  387    −0.29                              7.69E-01   8.44E-01   GSE1818          *Homo sapiens*        Cancer of the testis                                                                       Testis
  388    −0.29                              7.71E-01   8.44E-01   GSE10789         *Homo sapiens*        Leukemia, adult T cell                                                                     Blood monocyte
  389    −0.3                               7.66E-01   8.43E-01   GSE2368          *Mus musculus*        Ventilator-associated lung injury                                                          Lung tissue
  390    −0.32                              7.59E-01   8.38E-01   GSE11            *Mus musculus*        Type 1 diabetes mellitus                                                                   Splenic tissue
  391    −0.32                              7.44E-01   8.24E-01   GSE2507          *Mus musculus*        Muscular dystrophy                                                                         Myocardial tissue
  392    −0.34                              7.39E-01   8.21E-01   GSE11969         *Homo sapiens*        Adenocarcinoma of lung                                                                     Lung tissue
  393    −0.34                              7.29E-01   8.17E-01   GSE3             *Homo sapiens*        Chromophil carcinoma of kidney                                                             Renal cell
  394    −0.37                              7.05E-01   7.99E-01   GSE1710          *Homo sapiens*        Crohn\'s disease                                                                           Sigmoid colon
  395    −0.38                              6.97E-01   7.93E-01   GSE1987          *Homo sapiens*        Squamous cell carcinoma                                                                    Lung tissue
  396    −0.4                               6.96E-01   7.93E-01   GSE1719          *Homo sapiens*        Macular degeneration                                                                       Fibroblast
  397    −0.4                               6.91E-01   7.90E-01   GSE2737          *Homo sapiens*        Psoriasis vulgaris                                                                         Epidermis
  398    −0.41                              6.78E-01   7.81E-01   GSE2729          *Homo sapiens*        Rotavirus infection of children                                                            Peripheral blood mononuclear cell
  399    −0.41                              6.78E-01   7.81E-01   GSE14577         *Homo sapiens*        CFS                                                                                        Peripheral blood mononuclear cell
  400    −0.43                              6.66E-01   7.74E-01   GSE363           *Mus musculus*        Atherosclerosis                                                                            Hepatic tissue
  401    −0.46                              6.46E-01   7.57E-01   GSE1987          *Homo sapiens*        Adenocarcinoma of lung                                                                     Lung tissue
  402    −0.47                              6.42E-01   7.57E-01   GSE1786          *Homo sapiens*        Senescence                                                                                 Muscle, striated (skeletal) (MMHCC)
  403    −0.47                              6.33E-01   7.48E-01   GSE2018          *Homo sapiens*        Lung transplant rejection                                                                  Lung tissue
  404    −0.49                              6.26E-01   7.42E-01   GSE5113          *Mus musculus*        Intestinal flagellate infection                                                            Small intestinal lamina propria
  405    −0.52                              5.99E-01   7.19E-01   GSE4646          *Homo sapiens*        Meningococcal infection                                                                    Umbilical vein
  406    −0.54                              5.89E-01   7.15E-01   GSE3934          *Homo sapiens*        Meningococcal infection                                                                    Blood
  407    −0.54                              5.86E-01   7.13E-01   GSE11969         *Homo sapiens*        Squamous cell carcinoma of lung                                                            Lung tissue
  408    −0.55                              5.80E-01   7.08E-01   GSE3606          *Homo sapiens*        Overexertion                                                                               Leukocyte
  409    −0.59                              5.55E-01   6.99E-01   GSE2378          *Homo sapiens*        Glaucoma                                                                                   Astrocyte
  410    −0.61                              5.43E-01   6.86E-01   GSE11969         *Homo sapiens*        Large cell carcinoma of lung                                                               Lung tissue
  411    −0.63                              5.34E-01   6.77E-01   GSE1907          *Homo sapiens*        Sarcoidosis                                                                                Blood corpuscle
  412    −0.7                               4.74E-01   6.17E-01   GSE3100          *Mus musculus*        Cystic fibrosis                                                                            Lung
  413    −0.74                              4.62E-01   6.07E-01   GSE7277          *Mus musculus*        Arthritis                                                                                  frontal cortex
  414    −0.85                              3.97E-01   5.39E-01   GSE3384          *Mus musculus*        Nemaline myopathy                                                                          Gastrocnemius muscle
  415    −0.85                              3.95E-01   5.38E-01   GSE1363          *Mus musculus*        Primary pulmonary hypoplasia                                                               Lung tissue
  416    −0.86                              3.85E-01   5.26E-01   GSE11886         *Homo sapiens*        Ankylosing spondylitis                                                                     macrophage
  417    −0.9                               3.66E-01   5.05E-01   GSE1542          *Homo sapiens*        Duct cell carcinoma                                                                        Pancreas
  418    −0.94                              3.40E-01   4.81E-01   GSE3414          *Mus musculus*        SCID                                                                                       Lung tissue
  419    −1.04                              2.98E-01   4.35E-01   GSE2223          *Homo sapiens*        Anaplastic oligoastrocytoma                                                                CNS, brain (MMHCC)
  420    −1.11                              2.66E-01   3.97E-01   GSE1615          *Homo sapiens*        Polycystic ovary syndrome                                                                  Theca cells
  421    −1.17                              2.41E-01   3.70E-01   GSE1402          *Homo sapiens*        Chronic polyarticular juvenile rheumatoid arthritis                                        Peripheral blood mononuclear cell
  422    −1.18                              2.37E-01   3.65E-01   GSE5786          *Mus musculus*        Huntington\'s disease                                                                      CNS, brain, striatum (MMHCC)
  423    −1.23                              2.19E-01   3.42E-01   GSE3284          *Homo sapiens*        Bacterial infection                                                                        Leukocyte
  424    −1.28                              2.01E-01   3.18E-01   GSE3512          *Rattus norvegicus*   Hyperlipidemia                                                                             Hepatic tissue
  425    −1.29                              1.97E-01   3.16E-01   EXPE-MEXP-357    *Rattus norvegicus*   Hypertension                                                                               Left ventricle
  426    −1.36                              1.75E-01   2.88E-01   GSE4630          *Homo sapiens*        Hypoxia                                                                                    macrophage
  427    −1.38                              1.68E-01   2.80E-01   GSE1294          *Mus musculus*        Down's syndrome                                                                            CNS, brain (MMHCC)
  428    −1.39                              1.61E-01   2.70E-01   GSE5112          *Mus musculus*        Intestinal flagellate infection                                                            Intestinal epithelium
  429    −1.42                              1.53E-01   2.61E-01   GSE2006          *Homo sapiens*        Essential thrombocythemia                                                                  Thrombocyte
  430    −1.44                              1.46E-01   2.52E-01   GSE1402          *Homo sapiens*        Pauciarticular juvenile arthritis                                                          Peripheral blood mononuclear cell
  431    −1.54                              1.24E-01   2.25E-01   EXPE-MEXP-1283   *Homo sapiens*        Hodgkin's lymphoma                                                                         Peripheral blood mononuclear cell
  432    −1.63                              1.03E-01   1.94E-01   GSE1919          *Homo sapiens*        RA                                                                                         Synovial membrane
  433    −1.73                              8.56E-02   1.69E-01   GSE2395          *Homo sapiens*        Cystic fibrosis                                                                            Bronchial epithelium
  434    −1.74                              8.09E-02   1.60E-01   GSE6435          *Mus musculus*        Bacterial infection                                                                        Leukocyte, monocyte, macrophage (MMHCC)
  435    −1.76                              7.44E-02   1.50E-01   GSE1919          *Homo sapiens*        Osteoarthritis                                                                             Synovial membrane
  436    −2.77                              4.80E-03   1.74E-02   GSE10121         *Homo sapiens*        Squamous cell carcinoma of buccal mucosa                                                   Buccal mucosa

We computationally matched the juvenile plasticity signature to 436 disease signatures derived from public microarray data. This systematic method applies a rank-based molecular matching algorithm to determine the molecular concordance between the plasticity signature and a given disease signature, where high scores indicate that plasticity genes are significantly dysregulated by the disease and low scores indicate that the disease has no impact on plasticity genes. Highly ranked diseases included not only brain disorders known to disrupt plasticity such as Huntington's disease, but also non-neurologic disorders (e.g., bacterial infections, inflammatory bowel disease, metabolic diseases), suggesting that a broad range of disease states may impact molecular pathways involved in plasticity. ALS, Amyotrophic lateral sclerosis; AML, acute myeloid leukemia; APECED, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; CBCL, cutaneous B-cell lymphoma; CFS, chronic fatigue syndrome; CML, chronic myeloid leukemia; COPD, chronic obstructive pulmonary disease; DMD, Duchenne muscular dystrophy; FDIU, fetal death in utero; FDR, false discovery rate; GERD, gastroesophageal reflux disease; HIV, human immunodeficiency virus; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; IUGR, intrauterine growth retardation; JRA, juvenile rheumatoid arthritis; LGLL, large granular lymphocytic leukemia; MCTD, mixed connective tissue disease; MDS, myelodysplastic syndrome; MGUS, Monoclonal gammopathy of undetermined significance; MMHCC, Mouse Models of Human Cancers Consortium; MODY, maturity onset diabetes in youth type 1; MS, multiple sclerosis; PBL, peripheral blood lymphocyte; PTSD, post-traumatic stress disorder; RA, rheumatoid arthritis; SARS, severe acute respiratory syndrome; SCID, severe combined immunodeficiency.

![Inflammation induced by LPS suppresses experience-dependent plasticity in juvenile cortex. ***a***, Juvenile mice (P26) during the peak of ocular dominance plasticity were injected intraperitoneally with either LPS (300 μg/kg) or saline. ***b***, ***c***, Mice were either subjected to qPCR analysis of plasticity effectors from V1 4 h after the injection (***b***) or underwent 3 d of MD followed by *in vivo* extracellular recordings to assess ocular dominance plasticity (***c***). ***b***, LPS increased known plasticity brakes *PirB* and *H2K1*/*H2D1*, and decreased the plasticity trigger *BDNF*. LPS had no effect on the plasticity effectors *Nptx2*, *Lynx1*, *NogoR*, or *Ppp3ca*. Log2 FC (fold change) is −ΔΔ CT (*n* = 5 mice per group). Error bar indicates the SEM. \*\*\**p* \< 0.001, \*\**p* \> 0.001 and ≤0.01, \**p* \> 0.01 and ≤0.05 (*t* test of Δ CTs). ***c***, Neurons from peripheral LPS-treated mice (purple histogram: *n* = 7 mice, 129 cells) showed decreased cortical responsivity to light in the ipsilateral vs contralateral eye, as quantified by a reduced right shift in the ODS distribution after 3 d of MD compared with control saline-treated juvenile mice with MD (gray histogram: 6 mice, 135 cells; χ^2^ test of ODS distribution: *p* = 2.6 × 10^−6^). Animal-level quantification of ocular dominance plasticity by CBI reflects the extent of the ocular dominance shift after 3 d of MD (right-side plot; low CBI indicates higher plasticity). CBI was strongly increased in the LPS-treated group (purple discs: CBI = 0.64 ± 0.02, 7 mice) compared with saline-treated group (gray discs: CBI = 0.49 ± 0.04, 6 mice), indicating that proinflammatory LPS had suppressed developmental plasticity (LPS vs saline, \*\**p* = 6 × 10^−3^, one-sided *t* test). qPCR data are reported as the mean ± SEM. Horizontal bars for the CBI plot indicate the mean.](enu0061622030006){#F6}

Finally, we tested whether inflammation suppresses experience-dependent developmental cortical plasticity *in vivo*. We administered LPS (300 μg/kg, intraperitoneal) or saline on P26 immediately after suturing one eye to induce ocular dominance plasticity via monocular deprivation (MD; [Fig. 4a](#F6){ref-type="fig"}). After 3 d of MD, we conducted *in vivo* single-unit recordings of activity-driven changes in the eye preference of single neurons (ocular dominance) in binocular V1 in response to light ([@B20]). In mice treated with saline, we observed the expected shift in cortical responsivity to light stimulation from the deprived contralateral to nondeprived ipsilateral eye, as quantified by a decrease in the animal-level CBI (CBI = 0.49 ± 0.04; six mice; 135 cells), indicating the presence of developmental plasticity ([Fig. 4c](#F6){ref-type="fig"}, right-hand plot). In contrast, LPS significantly suppressed the shift in cortical responsivity from the deprived contralateral eye to the nondeprived ipsilateral eye, which was quantified by an increase in CBI and an elimination of the right shift in the distribution of ODSs of single neurons (CBI = 0.64 ± 0.02, seven mice, 129 cells; one-sided *t* test of CBIs: *p* = 0.006~l~; χ^2^ test of ODS distribution: *p* = 2.6 × 10^−6^~m~), indicating impaired plasticity during the critical period in V1 ([Fig. 4c](#F6){ref-type="fig"}, left-hand plot). Together, these data are consistent with our informatics-derived hypothesis by demonstrating that peripheral injection of LPS induces an inflammatory response in the brain and suppresses developmental cortical plasticity *in vivo.*

Discussion {#s5}
==========

Using an integrative bioinformatics approach, we found that inflammation disrupts developmental cortical plasticity. Our study demonstrates the utility of this approach for both identifying diseases that may disrupt plasticity and generating hypotheses on the molecular mechanisms underlying these disruptions. Moreover, our novel Disease Leverage Analysis facilitates novel hypothesis generation, because seemingly unrelated phenotypes, such as neuroplasticity and inflammation, can be connected based on apparently disparate tissues and diseases. Previous work indicating that the disease signal harmonizes across tissues ([@B14]) supports this approach and in the present study suggests that the molecular pathways underlying plasticity are shared in diverse tissues and are dysregulated in many disease states, including apparently non-neurological phenotypes (e.g., bacterial infections, inflammatory bowel disease, metabolic diseases). Importantly, the biological relevance of any given molecular match between plasticity and disease must be interpreted with care. In all cases, molecular matches indicate that plasticity and the disease phenotype share underlying molecular machinery. However, a given disease state in a specific tissue may or may not have an impact on functional plasticity or related gene expression if the disease state or tissue is sufficiently localized and segregated from neural tissue. Consequently, we developed Disease Leverage Analysis to use the information of all matches collectively to identify common disease processes and simultaneously shrink the hypothesis space to a manageable set of disease process-oriented hypotheses that bind together the diverse matches. This approach facilitated the unbiased and systematic use of apparently disparate disease signatures to generate novel hypotheses about shared disease mechanisms that may dysregulate plasticity. We find here that a common theme among these dysregulations is inflammation, a biological process that is well suited to communicate peripheral signals to the brain, disrupting plasticity.

We demonstrate several lines of evidence supporting a hypothesis that plasticity and inflammatory processes share components of underlying molecular networks. We computationally predicted associations between plasticity signature-perturbing diseases and TNF-α and IFN-γ pathways ([Figs. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}) and also experimentally identified associations between systemic inflammation and increases in the plasticity brakes *PirB* and *MHC-1* in the brain ([Fig. 4](#F6){ref-type="fig"}). These predictions and observations confirm the known role of pathways involving TNF-α, IFN-γ, Pirb, and MHC-I on regulating developmental plasticity ([@B59]; [@B29]; [@B11]; [@B46]) and extend them to the context of inflammation. We also showed that *BDNF*, a neurotrophic factor essential to the opening of the critical period ([@B26]), is decreased after LPS administration ([Fig. 4](#F6){ref-type="fig"}), which is consistent with the reported antagonistic relationship of peripheral LPS with BDNF ([@B22]; [@B52]). Interestingly, we also found that the microglial activator Lcn2 ([@B27]) is a member of both the juvenile and *Lynx1*^−/−^ plasticity signatures ([Tables 2](#T2){ref-type="table"}, [4](#T4){ref-type="table"}) and is dramatically increased after LPS in V1 during the critical period ([Fig. 3](#F5){ref-type="fig"}). Activation may inhibit microglia from carrying out their "resting-state" role in mediating experience-dependent plasticity ([@B55]), contributing to the dampening of plasticity by inflammation. Collectively, our work suggests a conflict between developmental cortical plasticity and immune-related molecular networks during inflammation, ultimately resulting in the suppression of plasticity during inflammation. Our study provides a novel subset of transcripts that can be used to guide future mechanistic studies into inflammation--plasticity interactions.

###### 

*Lynx1*^−/−^ plasticity signature

  RP         FC         pfp        *p* value   Probe_id       Symbol          mm_Entrez_ID   hs_Entrez_ID   Gene_name
  ---------- ---------- ---------- ----------- -------------- --------------- -------------- -------------- ------------------------------------------------------------------------------------------------
  1.2599     6.1102     0          0           ILMN_1213274   Ydjc            69101          150223         YdjC homolog (bacterial)
  26.1378    1.722      0          0           ILMN_2744660   Igh-6           NA             NA             NA
  87.0435    1.5896     0.0325     0           ILMN_1259747   Il33            77125          90865          Interleukin-33
  79.5578    1.583      0.0233     0           ILMN_1231445   Inmt            21743          11185          Indolethylamine *N*-methyltransferase
  99.1693    1.5584     0.0189     0           ILMN_1252675   D230019G01Rik   NA             NA             NA
  95.5604    1.5581     0.0267     0           ILMN_2499166   Tmem65          74868          157378         Transmembrane protein 65
  98.106     1.5481     0.0213     0           ILMN_1251713   Car12           76459          771            Carbonic anyhydrase 12
  94.6178    1.5436     0.032      0           ILMN_1244887   Gria4           NA             NA             NA
  96.4906    1.5339     0.0229     0           ILMN_2649671   Ipas            53417          64344          Hypoxia-inducible factor 3, α subunit
  122.0152   1.5276     0.035      0           ILMN_2680188   Bai1            107831         575            Brain-specific angiogenesis inhibitor 1
  137.2649   1.5013     0.04       0           ILMN_2968369   Kcnip1          70357          30820          Kv channel-interacting protein 1
  128.559    1.4989     0.0418     0           ILMN_2744657   Igh-6           NA             NA             NA
  135.6589   1.4911     0.0425     0           ILMN_3049896   Evi2b           NA             NA             NA
  295.2115   −1.4885    0.0464     3.00E-04    ILMN_2847144   Hist1h2ak       319169         221613         Histone cluster 1, H2ak
  271.4427   −1.5015    0.0389     2.00E-04    ILMN_2619455   Mcat            223722         27349          Malonyl CoA:ACP acyltransferase (mitochondrial)
  309.8626   −1.5083    0.0494     3.00E-04    ILMN_2700265   Pex11a          18631          8800           Peroxisomal biogenesis factor 11 alpha
  310.3477   −1.5135    0.0487     3.00E-04    ILMN_1254828   A730014O07Rik   NA             NA             NA
  306.798    −1.5145    0.049      3.00E-04    ILMN_2684693   Dusp3           72349          1845           Dual-specificity phosphatase 3 (vaccinia virus phosphatase VH1-related)
  307.0792   −1.5179    0.0488     3.00E-04    ILMN_2869715   Nell2           54003          4753           NEL-like 2
  277.2855   −1.5191    0.0393     2.00E-04    ILMN_2491589   Vgll4           232334         9686           Vestigial like 4 (Drosophila)
  311.6705   −1.5218    0.0487     4.00E-04    ILMN_2568488   A530089A20Rik   218914         23063          Wings apart-like homolog (Drosophila)
  300.5669   −1.5221    0.0474     3.00E-04    ILMN_2768841   Rab22a          NA             NA             NA
  312.3161   −1.5221    0.0484     4.00E-04    ILMN_3163448   Cdh8            12564          1006           Cadherin 8
  261.4704   −1.5237    0.0365     2.00E-04    ILMN_1214071   Ifitm1          68713          NA             Interferon-induced transmembrane protein 1
  273.6424   −1.5279    0.0394     2.00E-04    ILMN_2757232   Aqp4            11829          361            aquaporin 4
  285.8745   −1.5314    0.0422     3.00E-04    ILMN_1241551   Nell2           54003          4753           NEL-like 2
  240.2307   −1.534     0.0322     2.00E-04    ILMN_2629112   Asah3l          230379         340485         Alkaline ceramidase 2
  295.481    −1.5354    0.046      3.00E-04    ILMN_2688728   Pcyt1a          13026          5130           Phosphate cytidylyltransferase 1, choline, α isoform
  249.2494   −1.5366    0.0328     2.00E-04    ILMN_3151149   Cpne8           66871          144402         Copine VIII
  273.9191   −1.5385    0.0391     2.00E-04    ILMN_2657911   Cnot4           53621          4850           CCR4-NOT transcription complex, subunit 4
  309.8885   −1.5389    0.049      3.00E-04    ILMN_1257190   2900083I11Rik   58212          NA             Serine/arginine repetitive matrix 3
  269.2151   −1.5392    0.0385     2.00E-04    ILMN_2639849   Cbln4           228942         140689         Cerebellin 4 precursor protein
  290.2289   −1.5404    0.0445     3.00E-04    ILMN_1255457   Crebbp          12914          1387           CREB binding protein
  256.2379   −1.5408    0.0356     2.00E-04    ILMN_3072536   Eif5            217869         1983           Eukaryotic translation initiation factor 5
  242.1891   −1.542     0.0315     2.00E-04    ILMN_1249000   1500015O10Rik   78896          84417          RIKEN cDNA 1500015O10 gene
  306.5435   −1.5432    0.0494     3.00E-04    ILMN_1214405   Cnksr2          245684         22866          Connector enhancer of kinase suppressor of Ras 2
  278.6573   −1.5516    0.0393     2.00E-04    ILMN_2751988   Kitl            17311          4254           Kit ligand
  274.1734   −1.5518    0.0391     2.00E-04    ILMN_2673566   Eif4ebp2        13688          1979           Eukaryotic translation initiation factor 4E binding protein 2
  274.7663   −1.5538    0.0391     2.00E-04    ILMN_1216085   B230387C07Rik   106585         23253          Ankyrin repeat domain 12
  267.3929   −1.5547    0.0379     2.00E-04    ILMN_2703913   Mtf2            17765          22823          Metal response element binding transcription factor 2
  218.0454   −1.5569    0.03       1.00E-04    ILMN_2535881   Macrod2         72899          140733         MACRO domain containing 2
  298.574    −1.5571    0.0468     3.00E-04    ILMN_1246494   LOC381445       26422          26960          Neurobeachin
  240.5714   −1.5576    0.0318     2.00E-04    ILMN_1225224   Ttc14           67120          151613         Tetratricopeptide repeat domain 14
  257.4399   −1.5601    0.0364     2.00E-04    ILMN_1259724   Man1b           17156          10905          Mannosidase, α, class 1A, member 2
  225.5851   −1.5603    0.0305     1.00E-04    ILMN_1227376   BC042720        329178         285175         unc-80 homolog (*Caenorhabditis elegans*)
  233.0899   −1.5645    0.0306     1.00E-04    ILMN_2741677   Bach1           12013          571            BTB and CNC homology 1
  241.988    −1.5645    0.0319     2.00E-04    ILMN_1230312   A830054O04Rik   NA             NA             NA
  309.3927   −1.5684    0.0497     3.00E-04    ILMN_2793638   H2-Tw3          NA             NA             NA
  275.3065   −1.5696    0.0391     2.00E-04    ILMN_2757889   Zfp91-cntf      NA             NA             NA
  225.8264   −1.5706    0.0301     1.00E-04    ILMN_2654822   Chd4            107932         1108           Chromodomain helicase DNA binding protein 4
  247.466    −1.5728    0.0324     2.00E-04    ILMN_2731854   Creg2           263764         200407         Cellular repressor of E1A-stimulated genes 2
  218.4269   −1.5755    0.0297     1.00E-04    ILMN_1221598   9330133O14Rik   NA             NA             NA
  259.2859   −1.578     0.0363     2.00E-04    ILMN_1227149   Meg3            17263          NA             Maternally expressed 3
  245.0182   −1.579     0.032      2.00E-04    ILMN_2601176   Meg3            17263          NA             Maternally expressed 3
  246.2646   −1.5793    0.0323     2.00E-04    ILMN_1230605   Gm336           212285         116984         ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
  225.2295   −1.5805    0.0309     1.00E-04    ILMN_2638066   Gria3           53623          2892           Glutamate receptor, ionotropic, AMPA3 (alpha 3)
  224.7568   −1.5808    0.0311     1.00E-04    ILMN_1253224   Dhcr24          74754          1718           24-Dehydrocholesterol reductase
  204.3878   −1.5825    0.0256     1.00E-04    ILMN_2544603   2610015J01Rik   67039          NA             RNA binding motif protein 25
  190.3687   −1.5853    0.0233     1.00E-04    ILMN_2593230   Mllt4           17356          4301           Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
  190.5304   −1.5853    0.0225     1.00E-04    ILMN_2519673   Vwf             22371          7450           Von Willebrand factor homolog
  194.1056   −1.5868    0.0229     1.00E-04    ILMN_1215713   Egr4            13656          1961           Early growth response 4
  220.9951   −1.5896    0.0293     1.00E-04    ILMN_1239599   Bat2d           226562         23215          Proline-rich coiled-coil 2C
  218.0063   −1.5911    0.0304     1.00E-04    ILMN_2637413   Dbpht2          386753         NA             DNA binding protein with his-thr domain
  185.7923   −1.5957    0.023      1.00E-04    ILMN_1247295   Hook1           77963          51361          Hook homolog 1 (Drosophila)
  225.437    −1.5957    0.0309     1.00E-04    ILMN_2520582   Plxna4          243743         91584          Plexin A4
  204.4627   −1.6008    0.0249     1.00E-04    ILMN_2674890   Tbl1x           21372          6907           Transducin (β)-like 1 X-linked
  198.2794   −1.6018    0.0238     1.00E-04    ILMN_2541675   LOC382128       319675         85459          RIKEN cDNA 5830418K08 gene
  202.278    −1.6049    0.0251     1.00E-04    ILMN_2690603   Spp1            20750          6696           Secreted phosphoprotein 1
  204.4135   −1.6064    0.0252     1.00E-04    ILMN_1224992   Gcap14          72972          54462          Coiled-coil serine rich 2
  236.1982   −1.609     0.0309     2.00E-04    ILMN_1235124   Thsd4           207596         79875          Thrombospondin, type I, domain containing 4
  193.5829   −1.616     0.0231     1.00E-04    ILMN_2737867   Mtap1b          17755          4131           Microtubule-associated protein 1B
  219.8212   −1.616     0.0296     1.00E-04    ILMN_1254547   Nr4a2           18227          4929           Nuclear receptor subfamily 4, group A, member 2
  174.6364   −1.6168    0.0212     1.00E-04    ILMN_1235652   Usp37           319651         57695          Ubiquitin-specific peptidase 37
  190.4584   −1.6202    0.0229     1.00E-04    ILMN_1255854   Mtap9           213582         79884          Microtubule-associated protein 9
  183.2527   −1.6215    0.0226     1.00E-04    ILMN_3114632   Ddx6            13209          1656           DEAD (Asp-Glu-Ala-Asp) box polypeptide 6
  168.6428   −1.6221    0.0204     1.00E-04    ILMN_2561533   Vps13a          271564         23230          Vacuolar protein sorting 13A (yeast)
  169.7224   −1.6236    0.0204     1.00E-04    ILMN_1241229   Bat2d           226562         23215          Proline-rich coiled-coil 2C
  161.0071   −1.6316    0.0176     0           ILMN_1231734   Nsd1            18193          64324          Nuclear receptor-binding SET-domain protein 1
  228.5556   −1.6327    0.0303     1.00E-04    ILMN_1259781   A430041B07Rik   328108         23116          Family with sequence similarity 179, member B
  164.2141   −1.6332    0.0193     1.00E-04    ILMN_1250030   Cdc42ep1        104445         11135          CDC42 effector protein (Rho GTPase binding) 1
  186.6603   −1.6332    0.0229     1.00E-04    ILMN_2795040   Hist1h2ad       NA             NA             NA
  189.467    −1.6364    0.0239     1.00E-04    ILMN_1216322   Hmgcs2          15360          3158           3-Hydroxy-3-methylglutaryl-coenzyme A synthase 2
  189.7896   −1.6367    0.0235     1.00E-04    ILMN_2646070   Mtap1a          17754          4130           Microtubule-associated protein 1 A
  173.3318   −1.6391    0.0212     1.00E-04    ILMN_1229727   Gpr123          52389          84435          G-protein-coupled receptor 123
  182.5954   −1.642     0.0227     1.00E-04    ILMN_2715848   Slitrk4         245446         139065         SLIT and NTRK-like family, member 4
  154.7165   −1.6445    0.0157     0           ILMN_2481391   Zfp326          54367          284695         Zinc finger protein 326
  144.623    −1.6461    0.0132     0           ILMN_1224129   Dennd3          105841         22898          DENN/MADD domain containing 3
  175.2067   −1.6461    0.0208     1.00E-04    ILMN_2445958   Tssc8           63830          NA             KCNQ1 overlapping transcript 1
  201.9407   −1.6496    0.0253     1.00E-04    ILMN_3059326   Sparc           20692          6678           Secreted acidic cysteine-rich glycoprotein
  153.5956   −1.6636    0.0154     0           ILMN_3031781   Arid5b          71371          84159          AT-rich interactive domain 5B (MRF1-like)
  140.1691   −1.6694    0.0126     0           ILMN_2481389   Zfp326          54367          284695         Zinc finger protein 326
  134.6324   −1.67      0.0109     0           ILMN_1257525   Cpeb3           208922         22849          Cytoplasmic polyadenylation element binding protein 3
  135.784    −1.6706    0.0108     0           ILMN_1237548   5830407P18Rik   NA             NA             NA
  158.0665   −1.6714    0.0161     0           ILMN_1220048   A330086O21Rik   434089         NA             Predicted gene 10010
  131.7096   −1.672     0.0116     0           ILMN_1254296   Chd1            12648          1105           Chromodomain helicase DNA binding protein 1
  134.8336   −1.6821    0.0106     0           ILMN_2654932   Pdap1           231887         11333          PDGFA-associated protein 1
  156.3313   −1.6827    0.016      0           ILMN_2457731   A930010C08Rik   NA             NA             NA
  124.0646   −1.6846    0.0117     0           ILMN_2747381   Ddx24           27225          57062          DEAD (Asp-Glu-Ala-Asp) box polypeptide 24
  138.2192   −1.6875    0.0114     0           ILMN_1248181   Zbtb7a          16969          51341          Zinc finger and BTB domain containing 7a
  109.4147   −1.7232    0.0089     0           ILMN_2492395   2900064A13Rik   NA             NA             NA
  127.2584   −1.7307    0.0116     0           ILMN_1251488   A430041B07Rik   328108         23116          Family with sequence similarity 179, member B
  93.3629    −1.7373    0.0064     0           ILMN_1218471   3-Sep           24050          55964          Septin 3
  93.4053    −1.747     0.0062     0           ILMN_2675914   R3hdm1          226412         23518          R3H domain containing 1
  124.2134   −1.7587    0.0113     0           ILMN_2680128   Zc3h13          67302          NA             Zinc finger CCCH type containing 13
  80.5466    −1.7652    0.0055     0           ILMN_1239042   Ankhd1          108857         54882          Ankyrin repeat and KH domain containing 1
  86.1003    −1.7765    0.0054     0           ILMN_3162820   Odz4            23966          26011          Teneurin transmembrane protein 4
  82.5619    −1.7931    0.0057     0           ILMN_1236820   9430047F21Rik   NA             NA             NA
  134.4843   −1.794     0.0112     0           ILMN_2750515   Fos             14281          2353           FBJ osteosarcoma oncogene
  71.9896    −1.8054    0.0055     0           ILMN_1258834   Chd1            12648          1105           Chromodomain helicase DNA binding protein 1
  141.8688   −1.8109    0.0128     0           ILMN_3035795   Mllt3           70122          4300           Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
  271.3241   −1.8126    0.0392     2.00E-04    ILMN_2965669   Xlr4a           NA             NA             NA
  58.7952    −1.8477    0.0031     0           ILMN_2589525   Cpeb3           208922         22849          Cytoplasmic polyadenylation element binding protein 3
  108.4816   −1.8546    0.0093     0           ILMN_2803674   S100a9          20202          6280           S100 calcium-binding protein A9 (calgranulin B)
  73.6082    −1.8653    0.0057     0           ILMN_2639442   Rock2           19878          9475           Rho-associated coiled-coil containing protein kinase 2
  65.4886    −1.8737    0.0032     0           ILMN_2617920   1110017D15Rik   73721          84688          RIKEN cDNA 1110017D15 gene
  48.1193    −1.9436    0.0021     0           ILMN_1217776   Mll5            69188          55904          Lysine (K)-specific methyltransferase 2E
  53.5131    −1.9814    0.0027     0           ILMN_2702303   Ch25h           12642          9023           Cholesterol 25-hydroxylase
  43.2714    −2.0064    0.0015     0           ILMN_2649773   Slc38a5         209837         92745          Solute carrier family 38, member 5
  37.5276    −2.0092    9.00E-04   0           ILMN_1244343   B230369L08Rik   223697         25777          Sad1 and UNC84 domain containing 2
  41.0522    −2.0325    0.0017     0           ILMN_1226085   Syt1            NA             NA             NA
  30.3722    −2.0661    0.0011     0           ILMN_1256701   2900016B01Rik   74901          9920           Kelch repeat and BTB (POZ) domain containing 11
  33.181     −2.0665    0.001      0           ILMN_2778076   2210021J22Rik   72355          150383         Cysteine-rich, DPF motif domain containing 1
  61.2262    −2.0942    0.0029     0           ILMN_2668333   Prg4            96875          NA             Proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein)
  61.9241    −2.1057    0.0033     0           ILMN_2623983   Egr2            13654          1959           Early growth response 2
  18.8649    −2.4826    0.0014     0           ILMN_2652500   Lrg1            76905          116844         Leucine-rich alpha-2-glycoprotein 1
  13.3721    −2.4851    0          0           ILMN_2654906   Mgat3           17309          4248           Mannoside acetylglucosaminyltransferase 3
  25.6626    −2.6212    0.0012     0           ILMN_2710905   S100a8          20201          6279           S100 calcium binding protein A8 (calgranulin A)
  6.5864     −3.7552    0          0           ILMN_2712075   Lcn2            16819          3934           Lipocalin 2
  4.4996     −4.7574    0          0           ILMN_1243615   Gramd4          223752         23151          GRAM domain containing 4
  3.677      −5.3591    0          0           ILMN_1223734   Atf4            11911          468            Activating transcription factor 4
  2.1886     −7.3314    0          0           ILMN_2507182   Tomm22          223696         56993          Translocase of outer mitochondrial membrane 22 homolog (yeast)
  1          −13.9276   0          0           ILMN_1256369   Lynx1           23936          66004          Ly6/neurotoxin 1

V1 transcriptomes were profiled with microarray from *Lynx1*^−/−^ mice (the plasticity brake Lynx1 is genetically deleted to allow experience-dependent plasticity even in adulthood) to generate the *Lynx1*^−/−^ plasticity differential expression signature. Using RankProd differential expression (DE) analysis, V1 of adult *Lynx1*^−/−^ male mice \>P60 was compared with adult wild-type mice (\> P60; *n* = 3 each group) to identify 132 DE probes, which mapped to 107 unique mouse Entrez IDs. For downstream analysis, mouse Entrez IDs were mapped to human orthologs using the Mouse Genome Informatics homology reference to yield a 98 gene *Lynx1*^−/−^ plasticity signature. FC, fold change. RP, rank product. pfp, percent false positive (i.e. false discovery rate).

Our efforts to understand the molecular machinery involved in the suppression of developmental plasticity focused on immediate changes in gene expression in V1 via acute inflammation (qPCR 4 h after a single intraperitoneal injection of LPS). We expected this time point to be particularly sensitive to disruption because the earliest experience-dependent changes occur within hours to a day of MD at the level of firing rate of parvalbumin interneurons ([@B2]; [@B32]; [@B49]) and protease ([@B39]) and microglia activity ([@B55]) as triggers for subsequent global ocular dominance plasticity, which takes a few days to be detected by single-unit recordings ([@B20]). Importantly, such trigger events occur only during the juvenile critical period when our assay was performed, but not in the adult period ([@B32]). Thus, we reasoned that the baseline cortical expression signature at this early time point would be critical to gate global ocular dominance plasticity. In addition, peak acute inflammatory response, as measured by an increase in IL-1β in brain after peripheral LPS injection, is between 1 and 4 h ([@B33]; [@B15]; [@B50]), a time course well suited to disrupt these earliest experience-dependent plasticity events. While we speculate that LPS disrupted these early trigger events unique to juvenile cortex, more work needs to be performed to understand the molecular events underlying the functional changes seen within hours of MD and to dissect the impact of inflammation on these events. In addition to the early phase of plasticity, inflammation may also impact plasticity mechanisms during the later phases of MD because TNF-α is essential to nondeprived eye potentiation via a homeostatic mechanism at 5-6 d of MD ([@B29]). Ultimately, further work is necessary to tease out the interaction between inflammatory and plasticity mechanisms that contribute to the suppression of functional plasticity across multiple days of experience deprivation. Performing such work comparing acute versus chronic inflammatory models would provide fascinating insights into neuroimmune biology and would help to inform the important clinical question of the potential impact of acute and chronic inflammation on the neurodevelopmental trajectory in children.

While our experimental efforts focused on the impact of acute inflammation on plasticity, our list of diseases predicted to impact plasticity include diseases that accompany chronic inflammation ([Table 3](#T3){ref-type="table"}). Efforts to study human disease and animal models shed light on how acute versus chronic inflammation may affect plasticity. For example, components of plasticity and inflammation are dysregulated in epilepsy ([@B63]). Acute inflammation from low to high doses (LPS) decreases the threshold for the induction of seizure ([@B51]), and a single early life inflammatory insult increases susceptibility to seizure even into adulthood ([@B19]). Chronic overexpression of inflammation-related genes in rodents causes an increased or decreased susceptibility to seizure, depending on gene dose ([@B63]), and seizure itself appears to chronically induce inflammatory markers ([@B13]). This evidence indicates a potential bidirectional effect of epilepsy and inflammation, wherein acute and chronic inflammation may have immediate and long-term effects on epilepsy-related plasticity mechanisms. In addition to epilepsy, cortical lesions and hypoxia-ischemia induce a robust inflammatory response that can endure chronically ([@B6]; [@B54]) and disrupt ocular dominance plasticity weeks after the injury ([@B17]; [@B21]). Interestingly, anti-inflammatory (ibuprofen) treatment rescues MD-induced sensory learning (increased visual acuity of the nondeprived eye) in adult (P70--P110) after cortical injury via photothrombosis in the nearby primary somatosensory; however, ibuprofen did not restore ocular dominance plasticity ([@B21]). It is possible that the anti-inflammatory regimen or mechanism of action used was not sufficient to eliminate the inflammation and rescue ocular dominance plasticity, or it may reflect distinct mechanisms of plasticity and their modulation by inflammation in the juvenile cortex versus the adult. While it has been proposed that causes of plasticity disruption may be cortical deafferentiation in the case of cortical lesions or disruption of inhibitory interneurons in the case of hypoxia-ischemia, it is possible that inflammation downstream of injury disrupts plasticity and should be investigated further. In sum, there is evidence that chronic and acute inflammation go hand in hand with disrupted plasticity across a variety of brain disorders, on different time scales, and as a function of different underlying mechanisms. Going forward, work is necessary to understand the contribution of diverse inflammatory mechanisms in the disruption of various types of plasticity across a wide variety of neurological and neurodevelopmental conditions.

Our finding that inflammation suppresses developmental cortical plasticity suggests a potential public health concern related to neurodevelopmental trajectory. During the height of the critical period for visual plasticity (peak is 0.5--2 years in humans; [@B42]), children \<5 years of age have the highest incidence of contracting LPS-carrying Gram-negative foodborne pathogens relative to other childhood or adult periods ([@B8]). Other infections that induce inflammation also show an increased incidence during the peak of developmental plasticity in humans; \>80% of children \<3 years of age experience otitis media (ear infection; [@B38]) and children \<5 years of age are hospitalized for influenza-related complications nearly an order of magnitude more often than children 5--17 years of age (incidence rate ratio = 8.1, 95% CI = 7.3--9.0; data are from [@B12]). Our work suggests that this increased incidence of infection during postnatal periods of developmental plasticity (relative to older ages) may be an unrecognized mechanism by which inflammation alters the neurodevelopmental trajectory. Most directly, the suppression of visual cortex plasticity could disrupt the development of binocular matching ([@B64]), a process central to the development of normal vision that specifically depends on heightened plasticity during the critical period for visual development. In addition, higher-order cognitive processes could be disrupted, due to the hierarchical dependency of various critical periods of plasticity ([@B60]). In addition, given that mechanisms of plasticity identified in the visual critical period have translated to other brain regions and functions ([@B36]; [@B45]; [@B67]), it is likely that inflammation could disrupt plasticity in other systems.

Our work is a natural extension into the postnatal epoch of the growing body of research indicating deleterious brain and behavioral outcomes due to prenatal inflammatory exposure ([@B9]; [@B57]; [@B65]) and suggests that inflammation may have a more extensive impact on postnatal neurodevelopment and brain function than previously realized. In fact, childhood infections and inflammation are associated with subsequent diagnoses of autism, depression, and schizophrenia as well as declines in cognitive capacity ([@B10]; [@B1]; [@B30]; [@B5]). The elevated incidence rate of infections during childhood neurodevelopment (relative to older ages) and the association of childhood infection with subsequent neurodevelopmental disorder may indicate a partial explanation for the observed onset of psychiatric disorders in childhood and adolescence ([@B35]). Our work showing that inflammation disrupts developmental cortical plasticity suggests an unrecognized risk factor for neuropsychiatric disorders and provides a starting point to investigate the underlying pathophysiology.

We show here that an integrative bioinformatics approach is well suited to interrogate the interactions between disease processes and disruptions in developmental plasticity. To extend this approach further, molecular matching could be expanded to the \>71,000 experiments publically available (as of 4 August 2016, there were 71,885 Gene Expression Omnibus "Series"), and Disease Leverage Analysis could be expanded to the universe of biologically defined gene sets (as of 4 August 2016, MSigDb alone contained 13,311 sets), facilitating more comprehensive interrogation of the disease space and generation of more specific hypotheses about disease processes that disrupt plasticity. Moreover, this approach is not limited to interrogating neurodevelopment but can be extended to other neurological signatures beyond plasticity. We expect it will be useful for identifying connections between disease processes and other brain phenotypes that can be appropriately represented by a transcriptional signature.
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Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Henner Koch.

Two reviewers appreciate the significance of the work but ask for several points of clarification as well as some moderation of the interpretation. There is no need for additional experiments but the authors should provide a comprehensive and detailed response to the reviewers comments and revise the manuscript accordingly.

Reviewer \#1:

This manuscript applies bioinformatics to identify gene signatures correlated with the transcriptomic change occurring between P29 and \>P90. They interpret their data posing that the change in plasticity occurring at the end of the critical period is the most important functional change associated with this transcriptomic change. They find that inflammation is the biological function in common between age-dependent regulation of transcription and many disease signatures. Moreover, inflammation associated pathways are also regulated in adult Lynx Ko mice that display juvenile OD plasticity. Finally they test the role of inflammation by inducing systemic inflammation with IP injection of LPS in P26 mice and finding an impaired plasticity.

The approach is original and the results would be interesting, however there are many parts especially concerning Fig 2-4 that are not clearly described in the text and make difficult to judge the data.

In particular in the results section describing fig. 3 it is stated that

\"8 of 13 (61.5%) genes predicted to be anti-correlated to the plasticity signature showed a complete reversal in their differential expression pattern after LPS administration (all reversed genes p less than 5 x 10-4d, t-test of deltaCTs, n = 5 mice per group) (Figure 3)\" It is unclear where is this prediction coming from. If it is from GSE3253 (only stated in fig legend) these data were obtained by LPS injection in aged mice. Lowel\'s lab showed that OD plasticity continues to decrease with age, and aged mice are particularly impervious to monocular deprivation. Is the anticorrelation present at the whole transcriptome level? Moreover, is the fact that 13 genes are reversed significant? Why validation (done in juvenile mice) excludes few of the 13 genes? For example, judging from fig. 4b RT-PCR analysis BDNF is downregulated by LPS, however fig 3b would predict upregulation.

In the analysis of the Lynx KO the authors claim that inflammation is again involved. However, it should be clarified whether the regulated genes are the same (or significantly enriched with) genes of the P29 vs adult comparison albeit with opposite regulation, or whether different genes (even if belonging to similar categories) are involved.

Considering the results from Lowel\'s lab that a cortical lesion impairs OD plasticity the LPS ephys data are not so unexpected although I accept that they are needed to logically close the argument.

\"Mice that experienced opening of the sutured eye or that had poor recordings (less than 10 cells/mouse or less than 3 penetrations / mouse or lack of positive identification of monocular zone and secondary visual cortex) were excluded from further analysis\". How did the author perform identification of monocular and secondary visual cortices?

Reviewer \#2:

In this study the authors investigated the correlation between the transcriptome of a large number of diseases taken from public microarray data and the \"plasticity signature\" of the V1 area of the cortex (an area that is known to undergo a critical period with plasticity in juvenile mice). The plasticity signature was generated by comparing the transcriptome of juvenile and adult mice and also to adult Linx (-/-) mice (which have also a plasticity response in adulthood). They then used this plasticity signature to match it to the disease signatures of the public microarray data.In this first step the authors identified inflammation pathways to be related to a dysregulation of plasticity.

In a second step the authors used an experimental approach (LPS exposure) to verify their hypothesis concluded from the first step by artificially inducing an inflammatory response in mice and investigate, if similar signatures can be detected in the experimental model. Last the authors used an in vivo measurement of plasticity to show that the LPS exposure is suppressing the cortical plasticity response (in V1) in juvenile mice determined by a monocular deprivation test. The manuscript is well written and the overall findings of the study are interesting. The methods are appropriate and some important control experiments were performed. However, I have some concerns of the methods used and the interpretation of the data and think the caveats and limitations of the approach should be clearly stated in the discussion.

Concerns:

1\) The samples taken to generate the set of disease signatures stem from public microarray data and are derived from different tissues and also species (Table 2). The authors cite and propose that the study by Dudley et al., 2009 showed, that this is a valid approach. However, even in this original study, the authors provide some hints for limitations of the approach: \"We acknowledge several limitations to the approach taken by this study. Foremost, we acknowledge that experimental investigators will generally draw samples from tissues that are relevant to the disease condition under study. Therefore, we cannot assert that disease concordance would be maintained in samples drawn from tissues that would not commonly be chosen in the study of a disease\". So I think also in the discussion of this study this should be clearly stated to give the reader a fair impression of the caveats of the approach.

2\) The authors provide a nice experimental set to strengthen the hypothesis, that inflammation is sufficient to suppress plasticity in the model used. It would be interesting to know why the tissue samples were taken 4 hours after LPS injection and the in vivo measurements were done 3 days after LPS injection. Was it technically not possible to also take the tissue after the in vivo measurements? Maybe other signatures would be present at this time point? Also it might be that the plasticity response is still normal after 4 hours, since some plasticity changes occur only over longer time periods (i.e homeostatic plasticity, which was shown to be influenced by TNF-alpha and other inflammatory molecules.)

3\) The identified diseases include acute and chronic diseases. Several studies have proposed chronic inflammation as a potential cause of dysregulation of plasticity. Posttraumatic epilepsy, for example, has been linked to a dysregulation of the plasticity due to inflammation of neuronal networks (De Simoni et al. 2000, Vezzani - 2005). It would be nice to discuss the differential effects of chronic vs. acute inflamation on plasticity.

4\) Why did also diseases that have no clear neurological phenotype show a strong correlation in their transcriptomes found in this study. I think this also needs to be addressed in the discussion.
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